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Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
SYNTHESIS, SPECTRAL STUDIES AND THERAPEUTIC  
ACTIVITY OF SOME HETEROCYCLIC COMPOUNDS.  
 
 The research work presented in the thesis with the title, "SYNTHESIS, 
SPECTRAL STUDIES AND THERAPEUTIC ACTIVITY OF SOME 
HETEROCYCLIC COMPOUNDS" has been described as under.  
 
 The aim of research is to be develop new bioactive entitles, especially with 
biological activities bearing heterocyclic ring system namely Bis (2-Chloroethyl) 
amine 1, 3, 5-triazine molecules. Numerous heterocyclic compounds like chalcones, 
isoxazoles, pyrazolines, pyrimidines, cyanopyridines, cyanopyrans, quinoxalines, 
barbitones and thiosemicarbazides, triazoles have been synthesized.  
 
 1, 3, 5-triazine and Bis (2-Chloroethyl) amine represent one of the most class 
of compounds possessing a wide spectrum of bactericidal, fungicidal, anticancer, 
antiviral, anti-inflammatory activities etc. With a view of to synthesize some new s-
triazine, 2, 2-dichloro diethylamine derivatives which have been described as under.  
 
PART - I : STUDIES ON CHALCONES  
 
 Chalcones are Phenyl styrylketones containing reactive keto ethylenic group (-
CO-CH=CH-). Liturature serve reveals that chalcones derivatives possess 
antibacterial, antiviral, antifungal activities. Hence, it was thought worth while to 
synthesis chalcones derivatives of which have been described as under.  
 
Section-I : Synthesis and Antimicrobial activity of 2-{4'-[(3"-Aryl)-2"-Propene-
1"- one]-phenylamino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-
1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H
O
(Type-I) R = Aryl   
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 The chalcones of Type-(I) have been synthesized by the condensation of 2-
[(4'- acetyl) phenyl amino]-6-[Bis (2"-chloro ethyl)] amino-4-methoxy-1,3,5-triazine 
with aromatic aldehyde in presence of aqueous NaOH.  
 
PART - II : STUDIES ON ISOXAZOLES  
 
 Isoxazole derivatives are the potent biological activities, these have been 
reported to be active as antidepressants, antibacterial, antifungal, antiviral, 
antiinflamatory, analgesics and Bis (2-chloroethyl) amine possess anticancer, anti-
HIV activities. In order to achieving better potency to synthesize isoxazole derivatives 
which are described as under  
 
Section-1 : Synthesis and Antimicrobial activity of 2-{4'-[(5"-aryl)-Isoxazole-3"-
yl]- phenylamino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-
triazine.  
R
O
NNCl
N
N
NCl
O
N
H
(Type-II) R = Aryl  
   
 Isoxazole of Type-(II)-have been syntesized by chemoselective cyclisation 
between chalcones of Type-(I) with hydroxyl amine hydrochloride.  
 
 
PART - III : STUDIES ON PYRAZOLINES  
 
 Pyrazoline derivatives possess broad spectrum of pharmacological activities 
which are reflected by their use as analgesic, anticonvulsant, antimicrobial, 
antipyratics etc. The main moiety Bis (2-chloroethyl) amine, 1,3, 5-triazine nucleus 
have been reported to be active as antineoplastic agents with a view of above facts. 
Some new pyrazolines have been synthesized which have been described as under.  
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Section-I :  Synthesis and Antimicrobial activity of 2-{4'-[(5"-Aryl) 4", 5"-
dihydro-1"-(H)-Pyrazol-3"-yl]-phenylamino} –6-[Bis (2"'-chloroethyl) 
amino] – 4 - methoxy-1,3,5 - triazine.  
 
R
NH
NNCl
N
N
NCl
O
N
H
(Type-III) R = Aryl
 
 
 Pyrazoline derivatives of Type-(III) have been synthesized by the 
condensation of chalcones of Type-(I) with hydrazine hydrate.  
 
 
Section-II : Synthesis and Antimicrobial activity of 2-{4'-[(5"-aryl)-4", 5"- 
dihydro 1"-acetyl Pyrazol-3"-yl]-phenylamino} – 6 - [Bis (2"-
chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
 
R
N
NNCl
N
N
NCl
O
N
H
O(Type-IV) R = Aryl
 
   
 
 Acetyl pyrazolines derivatives of Type (IV) have been synthesized by the 
condensation of chalcones of Type-(I) with hydrazine hydrate and glacial acetic acid.  
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Section-III: Synthesis and Antimicrobial activity of 2-{4'-[(5"-Aryl)-4", 5"- 
dihydro-1"-Phenyl Pyrazole-3"-yl]-phenylamino} – 6 - [Bis (2"- 
chloroethyl) amino] – 4 – methoxy - 1,3,5 - triazine.  
R
N
NNCl
N
N
NCl
O
N
H
(Type-V) R = Aryl
 
 Phenyl Pyrazoline derivatives of Type-(V) have been synthesized by the 
condesation of chalcones of Type-(I) with phenyl hydrazine.  
 
PART-IV : STUDIES ON PYRIMIDINES  
 
 Pyrimidine nucleus possess remarkable pharmaceutical and biological 
activities. Pyrimidine derivatives are associated with various biological activities like 
antibacterial, antifungal, antitubercular, antimalarial, antitumor, antihypertensive etc. 
This valid observation led us to synthesize some new medicinally active compounds 
which have been described as under.  
 
Section-I:  Synthesis and Antimicrobial activity of 2-{4'-[(6"-Aryl)-2"-
mercapto-3”, 4”- dihydro- pyrimidine-4”-yl] -phenylamino} – 6 - 
[Bis (2"’- chloroethyl) amino] – 4 – methoxy - 1,3,5 - triazine.  
R
NCl
N
N
NCl
O
N
H
N
N
H
SH(Type-VI) R = Aryl
 
  Pyrimidine derivatives of Type-(VI) have been synthesized by the 
reaction of chalcones of Type-(I) with thiourea in the presence of alcoholic potassium 
hydroxide.  
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Section-II : Synthesis and Antimicrobial activity of 2-{4'-[(6"-Aryl)-2"-hydroxy-
3", 4" – dihydro – pyrimidine - 4" - yl] - phenylamino} – 6 - [Bis (2"' 
-  chloroethyl) amino] – 4 – methoxy - 1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H
N
N
H
OHR = Aryl(Type-VII)
 
 
 Pyrimidine derivatives of Type-(VII) have been synthesized by the reaction of 
chalcones of Type-(I) with urea.  
 
Section-III :  Synthesis and Antimicrobial activity of 2-{4'-[(6"-Aryl)-2"-amino-
3", 4" – dihydro – pyrimidine - 4" – yl ] – phenylamino } – 6 -
[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H
N
N
H
NH
2(Type-VIII) R = Aryl
 
 Primidine derivatives of Type-(VIII) have been synthesized by the reaction of 
chalocnes of Type-(I) with guanidine hydrochloride.  
 
PART-V : STUDIES ON CYANOPYRIDINES  
 
 In recent years, much interest have been focused of cyano pyridine derivatives 
showed wide range of application in the field of pharmaceutical. Cyano pyridine 
derivative have been reported to be active as antibacterial, antimalarial, 
antihypertensive, antineoplastic, antifungal, anticonvulsant etc. Considering these 
facts we thought it is worth while to syntesize some new cyanopyridine derivatives in 
association with s-triazine nucleus in search of better potential drugs. Which have 
been describe as under.  
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Section-I :  Synthesis and Antimicrobial activity of 2-{4'-[(6"-Aryl)-2"-amino-
3"-cyanopyridine-4"-yl]-phenylamino}-6-[Bis(2"'-chloroethyl) 
amino]-4-methoxy-1,3,5- trizine.  
R
NCl
N
N
NCl
O
N
H
N
NH
2
NC
(Type-IX) R = Aryl
 
 Pyridine derivatives of Type-(IX) have been synthesized by the reaction of the 
chalcones of Type-(I) with malono nitile in presence of ammonium acetate.  
 
 
Section-II :  Synthesis and Antimicrobial activity of 2-{4'-[(4"-Aryl)-3"-cyano-
2"-methoxy-pyridine-6"-yl]-phenylamino}-6-[Bis(2"'-chloroethyl) 
amino]-4-methoxy-1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-X) R = Aryl
 
 Pyridine derivatives of Type-(X) have been synthesized by the reaction of the 
chalcones of Type-(I) with malono nitrile in presence of sodium methoxide.  
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Section-III :  Synthesis and Antimicrobial activity of 2-{4'-[(4"-Aryl)-3"-cyano-
2"-ethoxypyridine-6"-yl]-phenylamino}-6-[Bis(2"'-chloroethyl) 
amino]-4-methoxy-1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-XI) R = Aryl
 
    
 Pyridine derivatives of Type-(XI) have been synthesized by the reaction of 
chalcones of Type-(I) with malonoitrile in presence of sodium ethoxide.  
 
Section-IV : Synthesis and Antimicrobial activity of 2-{4'-[(4"-Aryl)-3"-cyano-
2"-hydroxypyridin-6"-yl ] - phenylamino } - 6 - [ Bis (2"'- 
chloroethyl) amino] – 4 - methoxy-1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H N
OH
CN
(Type-XII) R = Aryl
 
 
 Pyridine derivatives of Type-(XII) have been synthesized by the reaction of 
the chalcones of Type-(I) with ehtyl cyano acetate in presence of ammonium acetate.  
 
 
PART-VI : STUDIES ON CYANOPYRANS  
 
 Cyanpoyran derivatives have been reported to various pharmacological 
activities like antibacterial, antiviral, antifungal etc. In order to develop better 
pharmacologically important compounds, it was considered of interest to synthesize 
some new cyanopyran derivatives shown as under.  
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Section-I : Synthesis and Antimicrobial activity of 2-{4'-[(2"-Amino-4"-Aryl-4"-
(H) – Pyran – 3 - carbonitrile) - 6" - yl] - phenylamino} – 6 - [Bis (2"' 
-chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
R
NCl
N
N
NCl
O
N
H
NH
2
CN
O
(Type-XIII) R = Aryl
 
   
 Cyanopyran derivatives of Type-(XIII) have been synthesized by the reaction 
of chalcones of Type-(I) with malononitrile in pyridine.  
 
PART-VII : STUDIES ON QUINOXALINES  
 
 Quinoxalines have been found to possess wide range of therapeutic activities 
and industrial importance. These significant biological properties have aroused 
considerable interest to design the compounds in which Bis (2-chloroethyl) amine, 
1,3,5-triazine nucleus in incorporated with a view to getting compounds with better 
potential drug.  
 
 Synthesis of quinoxalines of Type-(XIV) have been undertaken by the 
cyclocondensation of dibromo derivatives of chalcones of Type (I) with o-
phenylenediamine as under.  
 
Section-I :  Synthesis and Antimicrobial activity of [2"-Aryl-(quinoxaline)3-yl]-
(methylene phenylamino)-6-[Bis(2"'-chloroethyl) amino]-4-methoxy 
- 1,3,5 - triazine.  
R
N
N
NCl
N
N
NCl
O
N
H
(Type-XIV) R = Aryl
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 Quinoxaline derivatives of Type-(XIV) have been synthesized by the reaction 
of chalcones of Type-(I) with bromine in glacial acetic acid and O-phenylene 
diamine.  
 
PART-VIII : STUDIES ON BARBITONES  
 
 Barbituric acid derivatives are a wide spectrum of biological activites. Bis (2-
chloroethyl) amine, 1,3,5-triazine molecules possess diversified anticancer, anti-HIV, 
and other therapeutic activities, considering all the above facts, it was though that 
barbituric acid group could be introduced to moiety, which have been described as 
under.  
 
Section-I : Synthesis and Antimicrobial activity of 2-{4'-[(3"-Aryl)-2"-Propene-
1"- barbituric acid]-phenylamino}-6-[Bis(2"'-chloroethyl) amino]-4-
methoxy-1,3,5-triazine.  
NH NH
R
NCl
N
N
NCl
O
N
H
O
O
O
(Type-XV) R = Aryl
 
     
 Barbituric acid derivatives of Type-(XV) have been synthesized by the 
reaction of chalcones fo Type-(I) with Barbituric acid in galcial acetic acid.  
 
PART-IX : STUDIES ON THIOSEMICARBOXIMIDES  
 
 Thiosemicarboximes derivatives possess broad spectrum of therapeutic 
activity and antidiabetic, bactericidal, anticonvulsant, antipyretic etc, with a view of 
above facts to synthesize various thiosemicarboximes derivatives are represented as 
under.  
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Section-I :  Synthesis and Antimicrobial activity of 2-{4'-[(3"-Aryl)-2"-Propene-
1"- thiosemicarboximes] - phenylamino} – 6 - [Bis(2"'-chloroethyl) 
amino]-4-methoxy-1,3,5- triazine.  
R
N
NCl
N
N
NCl
O
N
H
N
H
NH
2
S
(Type-XVI) R = Aryl
 
 
 Thiosemicarboximes derivatives of Type-(XVI) have been syntheszied by the 
reaction of chalcones of Type-(I) with Thiosemicarbazide in alcohol.  
 
PART-X : STUDIES ON TRIAZOLES  
 
 Triazole derivatives possess wide spectrum of biological activity considering 
above facts, it was thought that triazole group could be introduced to moiety which 
have been described as under.  
 
Section-I :  Synthesis and Antimicrobial activity of 2-{4'-[(3"-Aryl)-2"-Propene-
1"-N-(1,2,4-triazole)amino]} – 6 - [Bis (2"' - chloroethyl) amino]-4-
methoxy - 1,3,5-triazine.  
N
R
N
NCl
N
N
NCl
O
N
H
N
N
(Type-XVII) R = Aryl
 
 
 Triazole derivatives of Type-(XVII) have been synthesized by the reaction of 
chalcones of Type-(I) with 4-amino-1,2,4-triazole in alcohol.  
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 The structure elucidation of the synthesized compounds have been done on the 
basis of elemental analysis, IR and 
1
H NMR spectroscopy and further supported by 
mass spectroscopy. The purity of the synthesized compounds checked by TLC.  
 
 All the compounds have been also evaluated for their antibacterial activity 
towards Gram +ve and Gram -ve bacteria and also evaluated antifunal activity at a 
concentration of 50µg/ml. The antimicrobial activity of the synthesized compounds 
have been compared with known standard drugs.  
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SYNTHESIS, SPECTRAL STUDIES AND  
THERAPEUTIC ACTIVITY OF SOME HETEROCYCLIC  
COMPOUNDS 
 
INTRODUCTION  
 Heterocyclic chemistry has been unparalled progress owing to their wide 
natural occurrence, specific chemical reactivity and broad spectrum utility.  
 
 Hetrocyclic compounds have great applicability in pharmaceutical, because 
they have specific chemical reactivity and provides false synthons in biosynthetic 
process.  
 
 Some heterocyclic compounds must ideally have a broad spectrum of activity 
with a rapid bactericidal action. We must always continue search new heterocyclic 
moleculer and identify its respective drugs activity. To take the care for synthesis new 
hetercyclic moleculer a lower toxicity, a partial or total absence of undesirable side 
effects, more neutritive value, improved stability, a decrease in production cost and 
check the qualitative or quantitative improvement in activity with standard drugs. Bis 
dichloro ethyl amine and s-triazene derivatives have been reported as a valuable 
medicine chemistry point of view e.g. anticancer, anthelmintic, antihistamine, Anti-
HIV, antimalarial, antiviral, antifungal etc. s-triazine, substitutents serves as nucleus 
to a host of compound which are associated with wide spectrum of therapeutic 
activity.  
 
 Heterocyclic compounds have great biological significance properties.  
(1) They have a specific chemical reactivity.  
(2) They resemble essential metabolism and can also provide false synthons in 
biosynthetic process.  
(3) They fit receptors and block their normal working.  
(4) They provide convenient building blockers to which biologically active 
substituent’s can be attached.  
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 The interesting biological activities of heterocycles have stimulated 
considerable research work in recent years including to the synthetic utility.  
 
 Heterocyclic compounds can be synthesised by cyclization reactions 
(accompanied by elimination of small molecules) addition reactions; (adduct 
formation), ring transformation reactions or replacement involving groups. Formation 
of heterocycle from acylic compounds alters the reactivity.  
 
AMIMS AND OBJECTIVES  
 Population of our country is skyrocketing number of diseases are uncoured 
e.g. cancer, Aids etc.  
 
 In the pharmaceutical field, there is a need for new and novel chemical 
inhibitors of biological functions. Our efforts are focused on the introduction of 
chemical diversity in the molecular frame work in order to synthesizing 
pharmacologically interesting heterocyclic compounds of widely different 
composition. During the course of research work looking to the applications of 
heterocyclic compounds, several entities, have been designed, generated and 
characterized using spectral studies. The aims and objectives of the work carried out 
are as under.  
 
(1) To synthesise pharmacologically active entities like chalcones, isoxazoles, 
pyrazolines, pyrimidines derivatives, cyanopyrans, quinoxalines, barbitonees, 
thiosemicarboximides triazoles bearing Bis-(2-chloro ethyl) amine and S-
triazine moiety.  
 
(2) To characterize these products for structural elucidation using spectroscopic 
technique like IR, 
1
H NMR and Mass spectral studies.  
 
(3) To check the purity of all compounds using thin layer chromatography.  
 
(4) To evaluate these new products for better drug potential against different 
strain of bacteria and fungi. Activity of synthesized compounds compared 
with known standard drugs.  
 
(5) Some compounds selected for anticancer activity.  
 
 The research work is presented as studies on Bis (2-chloro ethyl) amine and      
S-triazine molecules included in our moiety.  
 16 
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SUBJECT INTRODUCTION 
 
Bis(2-chloro ethyl) amine :  
 Literacher surve reveals that Bis (2-chloro ethyl) amine derivatives shows 
antineoplastic activity which are described as under.  
 
(i) 4-[Bis (2-chloroethyl) amino] Benzene butanoic acid "chorambicil" was 
reported as a antineoplastic agent.  
OH
O
N
Cl
Cl Chlorambucil
 
 [Ref. US 304301 [Boroughs well come (24-1-1962)] 
 
(ii) 5-[Bis (2-chloroethyl) amino]-2, 4-(1H, 3H) pyrimidinedione "Uracil mustard" 
or "uramustine" was reported antineoplastic agent.  
NH
N
H
O
O
N
Cl
Cl
  Uracil 
Mustard
 
[Ref. US 2969364 (Upjohn) (24-1-1961)] 
 
(iii) 4-[Bis (2-chloroethyl) amino] - 2- amino propanoic acid "Melphalan" was 
reported antineoplastic agent.  
N
Cl
Cl
NH
2
OH
O
Melphalan
 
 [Ref. US : 3032585 (Nat. Res. De V. crop) (1-5-1962)] 
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(iv) "Nimustine" N-[(4-Amino 2-methyl-5-pyrimidinly) methyl)-N-(2-chloro 
ethyl)-N-nitroso urea was reported as a antineoplastic agent.  
N
N
H
NH
2
N
H
N
Cl
O
NO
Nimustine  
 [Ref : US 4003901 Sankyo (18-1-1977)] 
 
(v) T. P. Johnston et. al. have been synthesised "Lomustine" as a antineoplastic 
agent.  
N
H
N
Cl
O
NO
Lomustine  
 [Ref : J. Med. Chem. (JMCMAR) 9, 892 (1966)] 
 
(vi) "Pipobroman", 1, 4-bis (3-bromo-1-oxo propyl) piperazine was reported as a 
antineoplastic agent.  
N
N
O Br
O Br
Pipobroman  
 [Ref : DE 113878 (Abbott : Appl, 10-10-1960)  
 Bis (2-chloroethyl) amine derivatives procuring better therapeutic activity. 
Looking at their versatile therapeutic importance introduced this group in our moiety.  
 
 
S-Triazine :  
 S-Triazine nucleus has been extensively explored for their applications in the 
field of medicine, agriculture and industrial chemisty. Although many substituted S-
 18 
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triazine compounds like other hetero cyclic compounds are synthesised with their 
functional group present froma cyclic compounds.  
  
 S-Trizine is a six membered heterocyclic ring having three nitrogen atom 
present at 1, 3, 5-position.  
N
N
N
1
2
3
4
5
6
 
S-Triazine derivatives possoss wide range of biological activities like herbicidal, 
anticancer, antibacterial, antifungal etc., with a view of getting to introduced this 
molecules in our moiety.  
 
(i) Shapiro et. al. have been reported N-Phenyl - 1, 3, 5-triazine-2, 4 diamine 
"Amanozine" as a diuretic drug.  
N
N
N
NH
2
N
H
Amanozine  
 [Ref : Shapiro, J. Am. Chem. Soc. 76, 93 (1954)]  
 
(ii) A. E. Johnson reported 2, 6-di (isopropyl amine)-4-methoxy-S-triazine 
"Prometon" as a herbicidal.  
N
N
O Br
O Br
Pipobroman  
 [Ref : A. E. Johnson Am. J. Vet. Res. 33, 1433 (1972)  
 
(iii) M. D. Incalci et al. have been synthesised 2, 4, 6-tris (dimethyl amino)-S-
triazine. "Altretamine" and reported as a antineoplastic agent.  
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N
N
N
NN
N
Altretamine  
 [Ref. M. D. In calci, Brit. J. Cancer, 41, 630 (1980).] 
 
(iv) Eichler, staib have been synthesised 2, 4, 6-tris (methylolamino)-1,3,5- 
triazine and reported it was a antineoplastic agent.  
N
N
N
N
H
N
H
NH
OHOH
OH
Tri methylol melamine  
(v) Thurston et. al. have synthesised 2-chloro-4, 6-Bis (ethyl amino)-s-triazine 
"Simazine" and reported its herbicidal activity.  
N
N
N
N
H
N
H
Cl
Simazine  
 [Ref. Thurston, ibid. 73, 2981 (1951)] 
 
(vi)  Kniisli have been synthesised 2, 4-bis-(ethyl amino)-6-(methlythio)-s-triazine 
"simetryne" represent herbicidal activity. 
N
N
N
N
H
N
H
S
Simetryne  
 [Ref. Kniisli, C.A., 57, 14226 (1962)]  
 
(vii) Taft et. al. have been synthesised 4-maino-N-(4, 6-diethyl-1,3,5-triazin-2-yl) 
benzene sulfonamide "Sulfasymazine" and reported as a antibacterial.  
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N
N
N
S
N
H
O
O
NH
2
Sulfasimazine  
 [Ref : Taft et al. J. Med. Chem. 8, 784 (1965)] 
 
 Thus the important role displayed by Bis (2-chloro ethyl) amine; S-Triazine 
and its deivatives shows various therapeutic and biological activity prompted us to 
synthesis some chalcones, pyrazoles, cyanopyridines, isoxazoles, pyrimidines, cyano 
pyrans, quinoxalines, barbitones, triazoles derivatives bearing in Bis (2-chloro ethyl) 
amine-S-triazine moiety in order to active compounds having better biological 
activities as described in the following parts.  
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PART - I  STUDIES ON CHALCONES  
 
PART - II STUDIES ON ISOXAZOLES  
 
PART - III STUDIES ON PYRAZOLINES  
 
PART - IV  STUDIES ON PYRIMIDINES  
 
PART - V  STUDIES ON CYANOPYRIDINES  
 
PART - VI STUDIES ON CYANOPYRANS  
 
PART - VII STUDIES ON QUINOXALINES  
 
PART - VIII STUDIES ON BARBITONES  
 
PART - IX STUDIES ON THIOSEMICARBOXIMIDES  
 
PART - X STUDIES ON TRIAZOLES  
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PART – I 
 
STUDIES ON CHALCONES 
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STUDIES ON CHALCONES 
INTRODUCTION  
 The chemistry of chalcones (M) have generated intensive scientific studies 
through out the world specially interesting are their biological and industrial 
applications. Chalcones are coloured compounds because of the presence of the 
chromophore, auxochromes. They are known as benzalacetophenones or benzylidene 
acetophenones. S. V. Kostanecki and J. Tambor
1
 have gave the name chalcone".  
 
 Chalcone are characterised by their possession of a structure in which two 
aromatic rings A and B are linked by an aliphatic three carbon chain.  
O
A B
(M)
 
 The alternative names given to chlacones are pheny1 styry1 ketones, 
benzalacetophenones. -pheny1 acry1phenone, -oxo- -dipheny1- -propy1- 
ene and -pheny1- -benzoethylene.  
 
SYNTHTIC ASPECT :  
 A considerable variety of methods are available for the synthesis of chalcones. 
The most convenient method is one that involves the Claisen-Schmidt condensation 
of equimolar quantities of an ary1 methy1 ketones with ary1 a1dehyde in presence of 
alcoholic alkali.
2
 
Several condensing agents used are alkali of different strength
3-4
, hydrogen 
chloride
5,6
, Phosphorous oxychloride
7
, Piperidine
8
, anhydrous Aluminium choride
9
, 
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Boron trifluoride
10
, aqueous solution of borax
11
,  amino acid
12
 and perchloric acid
13
 
etc.  
MECHANISM :  
 Chalcone formation proceeds through aldol type of condensation and the 
process is catalysed by the presence of alkali
14
, following steps of the reaction 
mechanism are as under.  
 
 The intermediate Aldol type of products formed readily undergoes 
dehydration even under mild condition, particularly when R and R' are aryl groups.  
 
REACTIVITY OF CHALCONES :  
 The chalcone have been found to be useful for the synthesis of variety of 
heterocyclic compounds are as under.  
(a) Pyrazolines
15
 and its derivatives can be prepared by the condensation of 
chalcones with hydrazine hydrate and acetic acid.  
(b) Chalcones on condensation with malononitrile and ammonium acetate yields 
2-amino-3-cyano pyridines
16
.  
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(c) Isoxazoles
17
 can be prepared by the treatment of chalcones with 
hydroxylamine hydrochloride and sodium acetate.  
(d) Chalcone on condensation with malononitrile in pyridine forms 2-amino 3-
cyanopyrans.
18
 
(e) Chalcones on treatment with urea in presence of alkali to affords 2-oxo 
Pyrimidines
19
.  
(f) Chalcones on reaction with thiourea in presence of alkali/acid yields 2-thio 
pyrimidines.
20
 
(g) Chalcones on treatment with guanidine hydrochloride in presence of alkali to 
affords 2-amino pyrimidines.
21
 
(h) Chalcones reacts with P2S5 yielding 2-isothiazolines.
22
 
(i) Chalcones with sodium nitrile in presence of glacial acetic acid in ethanol 
produces 2-(H)-pyrimidines.
23
 
(j) Chalcones with monoethanolamine in ethanol gives, 1, 4-oxazipines.
24
 
(k) Chalcones with 2-amino thiophenol in acetic acid produces 1, 5-thiazepines.
25
 
(l) Chalcones on reaction  with semicarbazide hydrochloride in ethanol affords l-
caroxamide pyrazolines.
26
 
(m) Chalcones on reaction with 2-aminopyrimidine in glacial acetic acid affords 
pyrido pyrimidines.
27
 
(n) Oxiran
28
 can be prepared by the reaction of chalcone with H2O2 in basic 
media.  
(o) Cyanopyridone
29
 derivatives can be prepared by the condensation of Chalcone 
with ethyl cyanoacetate.  
(p) Chalcones gives imine derivatives with amine in presence of sulphuric acid as 
a catalyst.
30
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(q) Chalcone on reaction with barbituric acid gave barbitone derivatives.
31
 
 
THERAPEUTIC INTEREST :  
 Chalcones are potential bioactive in nature, some naturally occuring 
antibiotics and amino chalcones probably own their biological activity to the presence 
of , -unsturated carbonyl group.  
 
(a) Insecticidal
32,33
 
(b) Antiulcer
34
 
(c) Antiinflammatory
35,36
 
(d) Bactericidal
37,38
 
(e) Fungicidal
39,40
 
(f) Antiviral
41
 
(g) Anthelmintics
42
 
(h) Antiallergic
43
 
(i) Carboxygenase inhibitor
44
 
(j) Antitumor
45,46
 
(k) Antimalarial
47
 
(l) Anticancer
48
 
(m) Antileishmanial
49
 
 
 Moreover, synthesis and antibacterial activity of substituted chalcone 
derivatives have been reported by S. R. Modi et al.
50
 and A. Attia
51
, V. R.  Mudalir et 
al
52
 have prepared phenoxy chalcones and observed their insecticidal activity. 
Kammei et al
53
. have been synthesised phenoxychalcones and observed their 
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insecticidal activity. R. De vincenzo et al
54
. and Han et al.
55
 have chalcone derviatives 
for their anti-inflammatory activity. Okuyana et al
56
. have been reported chalcone 
derivatives reductase inhibitor activity. Antitumor and antifungal activity as reported 
by A. Tsotitus and co-worker
57
. Antifeedant activity of chalcones have been observed 
by P. N. sharma and Sreenivasulu
58
. 
 Ezio Bombardelli et al
59
. have demonstrated that chalcone possess a valuable 
antiproliferation activity both on sensitive cancereous cell and on cell which are 
resistant to common chemotherapeutic drugs. S. Elichi et al. have been patented 
chalcones for their use for treatment of glaucoma
60
.  B. B. Kalashnikov et al.
61
 and S. 
Satoshi et al
62
 showed antifungal activity, P. Walavalker et al.
63
 showed aldose 
reductase inhibitor. O. tory et al
64
 evaluated anticancer activity. J. R. Dimmock. et 
al.
65
 and T. M. Abdel, Rahman
66
 evaluated antimicrobial activity.  
 Recently, Ni Liming et al.
67
 have synhesised chalcones and screened for  their 
antiinflammatory and cardiovascular activity. Kumar Srinivas et al
68
. have 
synthesised chalcones as a antitumor agent. Ko Horng Huey et al
69
. have prepared 
chalcones as antiinflammatory agent. Nakahara Kazuhiko et al
70
. have synthesised 
chalcones as carcinogen inhibitors and antitubercular agents.  
 Lin Yah meei et al
71
 have  synthesis chalcones derivatives.  B. R. Das et al
72
. 
have found that chalcones possesses larvicidal properties. Kirm Min Young et al
73
. 
have synthesised chalcones and tested for their matrixmetalloproteinase inhibitor 
activity.  
 
 Liu Mei et al
74
. have been prepared chalcones and evaluated antimalarial 
activity. O. veronika et al
75
  have synthesised chalcones and screened as 
cardiovascular agent.  
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Moreover, it has been found that chalcone derivatives possesses nitric oxide 
inhibitor
76,77
 and  anti-HIV
78
 activities.  
 
Contribution in our laboratory :  
 D. M. Purohit et al
79
 have been synthesised 2-(4'-chlorophenyl)-6-methyl-3-
[1"aryl-2"-propene-1"-ones-3-yl]-imidazo (1, 2-a] pyridine and evaluated their 
antimicrobial activity.  
N
N
R
Cl
O
R = aryl
 
 Chalcones bearing a very good synthon, variety of novel heterocycles with 
good pharmacological profile can be designed. These valid observation led us to 
explore chalcones chemistry by synthesising several derivatives like isoxazoles, 
pyrazolines, pyrimidines, cyanopyrans etc bearing different heterocyclic ring systems 
for medicine value, in order to achieving bettter therapeutic agents, these study 
described as under.  
 
SECTION-1  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
[(3"-ARYL)-2"'-PROPENE-1"-ONE]-  PHENYLAMINO}-6-
[BIS-(2"-CHLOROETHYL) AMINO] -4-METHOXY-1, 3, 5-
TRIAZINE. 
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SECTION-I 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-
PROPENE-1"-ONE]-PHENYLAMINO}-6-[BIS-(2"-CHLOROETHYL)AMINO]-4-
METHOXY-1, 3, 5-TRIAZINE. 
 Recently much interest has been focoused on the synthesis and biodynamic 
activities of chalcones and it is a good synton for various heterocyclic rings, with a 
view to obtained compounds having better therapeutic activity of 2-{4'[(3"-aryl)-2"-
propene-1"-one]-phenyl amino}-6-[Bis(2"-chloroethyl)amino]-4-methoxy-1, 3, 5-
triazine of type- (I) have been synthesised by the condensation of 2-[(4'-acetyl)phenyl 
amino]-6-[Bis-(2"-chloroethyl)amino]-4-methoxy-1,3,5-triazine with aromatic 
aldehyde in presence of aq. NaOH. 2-(4'-acetyl phenyl amino)-4,6-dichloro-S-triazine 
have been synthesis by the condensation of cyanyric chloride with 4-amino 
acetophenone at 0° c temp. in the presence of aq. NaOH. 2-(4'-acetyl phenylamino)-6-
chloro-4-methoxy-S-triazane have been synthesised by the condensation of 2-(4'-
acetyl phenyl amino)-4-6-dichloro-S-triazine with sodium methoxide at room temp. in 
methanol. The 2-[(4'-acetyl phenyl) amino]-6-[Bis-(2''-chloro ethyl)amino]-4-
methoxy-1,3,5-triazine have been synthesized by the condensation of 2-(4'-acetyl 
phenyl amino)-6-chloro-4-methoxy-S-triazine with 2,2'-dichloro diethyl amine 
hydrochloride in the presence of aq. NaOH and dioxane at 110° c temp. 
R
NCl
N
N
NCl
O
N
H
O
(Type-I) R = Aryl  
 The constitution of the synthesis products have been characterized by 
elemental analysis, IR, 
1
HNMR and mass spectral study. The product were screened 
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for antimicrobial activity at a concentraion of 50 μg/ml. The details have been cited in 
the part-I section-I, Page no. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[3"-(4"'-METHOXY PHENYL)-2"-
PROPENE-1"-ONE]-PHENYLAMINO-6-[BIS(2"-CHLOROETHYL)AMINO]-
4-METHOXY-1,3,5-TRIAZINE 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophotometer; frequency range : 4000-400cm
-1
 (KBr disc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
Ketone 
S-triazine 
 
Amine 
 
Vinyl 
Ether 
 
Halide 
 
C-H  Str.(Asym) 
C-H  Str.(asym) 
C-H  Str.(Asym) 
C-H  Str.(asym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C=O  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H Bending 
CH=CH 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
 
2923 
2852 
1436 
1371 
3097 
1276 
821 
1517 
1677 
1118 
1589 
3311 
1649 
3045 
1245 
1037 
768 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1700-1640 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
3050-3000 
1260-1220 
1075-1020 
800-600 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[3"-(4"'-METHOXY PHENYL)-2"-
PROPENE-1"-ONE]-PHENYLAMINO]-6-[BIS-(2"-
CHLOROETHYL)AMINO] - 4 -METHOXY - 1, 3, 5-TRIAZINE.  
 
 
Internal standard : TMS , Solvent : CDCl3 Instrument : BRUKER Spectrometer (300 mhz) 
 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
3.62-3.86 
7.01-7.03 
8.08-8.12 
4.79-4.80 
2.50-2.51 
9.95 
4.80-4.83 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Doublet 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
-NHf 
-CH=CHg- 
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MASS SPECTRAL STUDY OF 2-{4'-[3"-(4"'-METHOXY PHENYL)-2"-PROPENE-1"-ONE]-PHENYL AMINO]-6-[BIS-(2"-
CHLOROETHYL)AMINO] - 4 -METHOXY - 1, 3, 5-TRIAZINE. (M.W. : 502) 
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Antimicrobial Activity: 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
  
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4 Br. C6H4-(21) 3-OH C6H4-(19) C6H5-(18) 4-OH C6H4-((21) 2-OH C6H4-(22) 
 4-NO2 C6H4 (21) 4-OCH3C6H4(18) 4-OH C6H4-(20) 4-NO2 C6H4-(22) 3-OH C6H4-(21) 
  4-N,N-(CH3)2C6H4(18) 4-Br C6H4-(21)  4-OH C6H4-(23) 
   4-NO2 C6H4-(20)  4-Br C6H4-(20) 
 
   Comparable activity with known standard drugs  
 
Ampicilin (50µg/ml.) 23 18 17 27 - 
Chloramphenicol  “ 24 19 25 26 - 
Norfloxacin          “ 24 19 25 26 - 
Greseofulvin           “ - - - - 23 
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Reaction Scheme 
 
 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
(Type-I) R = Aryl
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
SYNTHESIS OF 2-{4'-(3"-ARYL) -2"-PROPENE-1"-ONE]-PHENYL 
AMINO]-6-[BIS-(2"'-CHLOROETHYL)AMINO] - 4 -METHOXY - 1, 3, 5-
TRIAZINE. 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1, 3, 5-triazine.  
 A mixture of 2, 4, 6-trichloro-s-triazine (1.845 gm, 0.01M), 4-amino 
acetophenone (1.35 g, 0.01M) in acetone (25 ml.). and aq. NaOH solution till solution 
basic. The reaction mixture was stirring at 0
0
c temp. for 5 hrs. The content was poured 
into crushed ice, filtered and washed with water. The isolated product was crystallised 
from dioxane yield : 82% mp. 112ºC. 
(found : C : 46.61;, H : 2.79; N : 19.75; C11H8N4OCl2,  required C: 46.64, H: 2.82; N : 
19.79%)  
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro - 4- methoxy-1, 3, 5- 
traiazine.  
 A mixture of 2-(4'-acetyl phenyl amino) - 4, 6-dichloro-1,3,5  trizine (2.83 gm, 
0.01 M); sodium methoxide (0.56 gm, 0.01 M) in methanol. The reaction mixture was 
strrring at room temp. for 7 hrs. The content was poured into crashed ice, filtered and 
wash with water. The isolated product was crystallised from dioxane. Yield : 86%, 
M.P. 178º c.  
(found C: 51.65; H : 3.91; N : 20.09 C12H11N4O2Cl required C : 51.70; H : 3.94; N : 
20.10%) 
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(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"-chloro ethyl)amino]-4-
methoxy-1,3,5-triazine.  
 A mixture of 2-(4'-acetyl phenyl amino)-6-chloro-4- methoxy-1,3,5-triazine 
(2.78g., 0.01 M.) 2,2'-di chloro diethyl amine hydrochloride (1.43 gm, 0.01M); 
dioxane (25 ml) and aq. NaOH. The reaction mixture was refluxed at 110º C for 6 hrs. 
The content was cooled and poured into crushed ice, filtered and washed with water. 
The isolated product was crystallised from dixoane. Yield 79% ; mp 249º C.  
(Found : C : 49.88, H : 4.91. N : 18.19 C16H19N5O2Cl2 reqired C : 50.00; H : 4.94; N : 
18.22%) 
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(D)  Synthesis of 2-{4'-[3"-(4"''-Methoxy phenyl) -2"-propene - 1" - one] 
phenyl amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 A  mixture of 2-(4'-acetyl phenyl amino) - 6- [Bis (2" - chloro ethyl) amino]-4 
- methoxy - 1, 3, 5-triazine (3.84 gm, 0.01M); 4-methoxy benzaldehyde (1.36 gm, 
0.01M), methanol (25 ml.) add 40% NaOH solution till becomes basic medium. The 
reaction mixture was stirring 24 hrs. at room temp. The contents were poured into 
crushed ice, acidified filtered and crystallized from dioxane. Yield : 79%, M.P : 
198ºC. (Found: C : 57.31; H : 4.90; N : 13.91; C24H25O3N5Cl2 C : 57.37; H : 4.98; N : 
13.94%) 
 Simillarly other chalcones were prepared and their physical data are recorded 
in Table No. 1  
 
(E) Antimicrobial activity of 2-{4'-[(3"-Aryl) - 2" - Propene - 1"-one] 
phenylamino}-6-[Bis (2'"-chloroethyl) amino]-4-methoxy - 1, 3, 5 triazine.  
 The antimicrobial testing was carried out as described in Part : I, Section : I, 
Page No. 39-41.  
 The zone of inhibition of the test solution are recorded in Table No. 2.  
 
(F) Antimicrobail activity of 2-(4'-Acetyl phenyl)-6-[Bis(2"-
chloroethyl)amino]4-methoxy-1,3,5-triazine.  
 Method : It was carried out using the cup-plate method which has been 
described as under.  
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Antibacterial activity :
80
 
 The Purified products were screened for their antibacterial activity. The 
neutrient agarbroth prepared by the usual method, was inoculated specially with 0.5 
ml for 24 hours, old subsclture of B. megaterium Bacillus subtillis Escherichia coli, 
pseudonomus fluorescens, in separate concial flasks at 40-50
0
C and mixed well by 
gentle shaking. About 25 ml of the contents of the flask were poured and evenly 
spread in a petridish (13 cm in diameter) and allowed to set for 2 hrs. The cups (10 
mm in diameter) were formed by the help of borer in a agar medium and filled with 
0.10 ml (1.0 g/ml) solution of sample in dimethyl formamide.  
 The plates were incubated at 32
0
C for 24 hrs. and the control was also 
maintained with 0.1 ml of DMF in similar manner and the zone of inhibition of the 
bacterial growth are  measured in mm, diameter  are recorded in Table No. A.  
Antifungal activity
81
 
 Aspergillus awamori was employed for testing fungicidal activity using cup-
plate method the cultures were maintained on subouraud's agar slants. Purified 
compounds were used for testing the fungicidal activity, sterlised subouraud's agar 
medium was inoculated with 72 hours old 0.5 ml suspension of fungal spores in a 
sterilised sepearate flask. About 25 ml of the inoculated medium was evntly spreaded 
in a petridish and allowed to set for 2 hrs. The cups (10 mm in a diameter) were 
punched in petridish and loded with 0.1 ml (1.0 mg/ml) of solution of a sample in 
DMF.  
 
 The plate were incubated at room temp. 37
0
 C for 48 hrs. After the completion 
of incubation period. The zone of inhibition or growth in the form of diameter in mm 
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was measured. Along the test solution in each petridish one cup was filled up with 
solvent acts as control. The zone of inhibition are recorded in Table No.A  
 
ANTIMICROBIAL ACTIVITY 
Product    : 2-[(4'-acetyl phenyl) amino]-6-[Bis(2'-chloro 
     ethyl) amino]-4-methoxy-1,3,5 triazine 
Method    : Cup plate  
Gram Positive Bacteria  : Bacillus megaterium  
     Bacillus subtillis  
Gram Negative Bacteria : Escherichia Coli  
     Psenudonomus Fluorescens  
Fungi     : Aspergilus awamori  
Concentration   : 50 µg  
Solvent    : Dimethyl formamide  
Standard Drugs  : Ampicillin, chloramphenicol, Norfloxacin,  
     Greseofulvin  
 
 The antibacterial activity was compared with standard drugs viz. ampicillin, 
chloramphenicol, norfloxacin and antifungal activity was compared with standard 
drug viz. greseofulvin. The Zones of inhibition were measured in mm. The Zones of 
inhibition that displayed by standard drugs are recorded in Part-I, Page No. 41. 
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TABLE NO. A : ANTIMICROBIAL ACTIVITY; ZONE OF INHIBITION FOR STANDARD DRUGS  
 
Sr. 
No. 
Standard 
Drugs 
Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 Ampicilin (50 µg) 23 18 17 27 - 
       
2 Chloramphenicol (50 µg) 24 19 25 26 - 
       
3 Norfloxacin (50 µg) 24 19 25 26 - 
       
4 Greseofulvin (50 µg) - - - - 23 
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TABLE NO. : 1  PHYSICAL CONSTANT OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-ONE] PHENYLAMINO}-6-[BIS(2"-CHLORO 
ETHYL)-AMINO]-4- METHOXY-1, 3, 5-TRIAZINE 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5
-
 C23H23Cl2N5O2 218 70 14.83 14.80 
2. 2-OH C6H4
-
 C23H23 Cl2N5O3 224 82 14.34 14.31 
3. 3-OH C6H4
-
 C23H23Cl2N5O3 230 85 14.34 14.32 
4. 4-OH C5H4
- 
 C23H23Cl2N5O3 220 81 14.34 14.29 
5. 4-OCH3 C6H4- C24H25Cl2N5O3 198 79 13.94 13.91 
6. 4-OH, 3-OCH3 C6H3- C24H25Cl2N5O4 231 83 13.51 13.49 
7. 4-Br. C6H4- C23H22Br Cl2N5O2 172 86 12.70 12.69 
8. 3-NO2 C6H4- C23H22Cl2N6O4 222 89 16.24 16.22 
9. 4-NO2 C6H4- C23H22Cl2N6O4 175 81 16.24 16.21 
10 4-N, N-(CH3)2 C6H4- C25H28Cl2N6O2 226 78 16.30 16.25 
11. C4 H3O (Furfuryl) C21H21Cl2N5O3 238 83 15.15 15.10 
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TABLE NO. 2 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-ONE] PHENYLAMINO}-6-[BIS(2"-
CHLORO ETHYL)-AMINO]-4- METHOXY-1, 3, 5-TRIAZINE 
 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
 B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 16 13 18 19 17 
2 2-OH C6H4 17 15 17 18 22 
3 3-OH C6H4 19 19 16 19 21 
4 4-OH C5H4 20 17 20 21 23 
5 4-OCH3 C6H4 15 18 18 17 16 
6 4-OH, 3-OCH3 C6H3 18 14 16 22 18 
7 4-Br. C5H4 21 19 21 18 20 
8 3-NO2 C6H4 17 16 18 19 17 
9 4-NO2 C6H4 21 17 20 22 19 
10 4-NN-(CH3)2 C6H4 15 18 17 17 18 
11 C4 H3O (Furfuryl) 14 15 16 19 17 
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PART - II 
STUDIES ON ISOXAZOLES 
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STUDIES ON ISOXAZOLES 
INTRODUCTION  
 Isoxazoles.(N) are a group of heterocyclic compounds containing two hereo 
atoms : oxygen and nitrogen.  
O
N
(N)  
 In 1888 claisen first suggest in isoxazoles (N) for a product from the reaction 
of 1, 3 diketone with hydroxylamine
82
 subsequently a solid foundation for the 
chemistry of isoxazoles was laid down by claisen and his students. It was shown to 
possess typical properties of an aromatic system but under certain reaction conditions, 
particularly in reducing or basic media, it becomes very highly labile. The next 
important contribution to the chemistry of isoxazoles was made by Quelico in 1946 
when he began to study the formation of isoxazoles from nitrile N-oxides and 
unsaturated compounds.
83
 
 
SYNTHETIC ASPECT :  
 Isoxazole may be prepared by the reaction between hydroxylamine and -
unsaturated compounds the reaction proceeds Via the formation of an oxime. Which 
possibly undergoes cylization.  
R
O
R'
O
O
N
H
O
R'
R
O
N
H
R
R'
OH
NH2OH Keto-Enol
O
N
R
R'
- H2O
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 Isoxazole can be prepared by various methods which are described as under. 
L. S. Crawley
84
 prepared isoxazole from chalcones hydroxylamine hydrocloride and 
KOH in methanol.  
R
O
R'
O
N
R
R'
NH2OH
 
THERAPEUTIC IMPORTANCE  
 Isoxazole possess wide therapeutic activites which are as under.  
(a) Antiinflammatory
85,86,87,88
 
(b) Antivonvulsant
89,90
 
(c) Muscle relaxant
91,92
 
(d) Antipyretic
93
 
(e) Anticholestemic
94
 
(f) Antibacterial
95,96,97
 
(g) Diabetic
98
 
(h) Nematocidal
99
 
(i) Fungicidal
100,101
 
(j) Antiviral
102
 
(k) Herbicidal
103,104,105
 
(l) Anthelmintics
106
 
(m) Antileukemia
107
 
(n) Antitumor
108
 
(o) Hypoglycemic
109
 
(p) Analgesic
110
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 B. Maggio et al
111
 synthesised novel 3-(isoxazol-3-yl)-quinazolin-4-(3H)- one 
derivatives and tested for their analgesic and antiinflammatory activities, as well as 
for their actual toxicity and ulcerogenic effect. Some of them had a very low 
ulcerogenic effect.  
 
 C. B. Xue et al
112
 reported the replacement of the benzamide in XUO57 
(potent inhibitor) with an isoxazole carboxamide resulted in significant improverment 
in vitro potency. More importanty the analogue XXUO65 showed on excellent oral 
antiplatelet effect in dogs.  
 
 M. Masui et al.
113
 have prepared isoxazoles having pesticidal activity. Some 
excellent herbicidal results obtained by K. V. Reddy et al.
114
 Moreover isoxazoles 
found to possess remarkable anixolytic and antihypertensive effect, reported by J. 
Nyitrai et al.
115
, A. Mishra et. al.
116
 have synthesised and reported isoxazoles as useful 
agents for analgesic and antiinflammatory activities. T. D. Aicher et al.
117
 reported 
some isoxazole derivatives possessing hypoglycemic agents.  
 
 S.Ozkan et al.
118
 have prepared 3-(1-phenyl-1,2,3-triazol-4-yl) benziscreazoles 
(O) and studied their insecticidal acitvity.  
N
N
Ph
O N
Y
z
N
(O)  
 M. Dauria
119
 studied photochemical behaviour of isoxazole derviatives. Y. N. 
Manohara et at.
120
 ivestigated thermal decomposition kinetics of Co (II) and Ni (II) 
complexes of substituted isoxazole and their antibacterial activity. A. R. Parikh and co 
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worker
121
 have prepared isoxazole derivatives and documented antitubercular activity. 
Some isoxazoles are found to possess herbicidal
122-124
 Potential anti-
inflammatory
125,126
 and antimicrobial agents
127,128
 estrogen receptor modulators
129
 and 
inhibior of P38 MAP kinose activities.
130
 
 
Contribution in our Laborartoy : 
 D. M. Purohit et al
131
 have been synthesised 2-(4'-chloro phenyl)-6-methyl-3-
[3"-arylisoxazol-5"-yl)-imidazo[1,2,-a] pyridine  
N
N
N
O
R
Cl
R = aryl
 
 When an intension of the compounds possessing better therapeutic activity we 
have undertaken the synthesised of isoxazoles bearing Bis (2-chloro ethyl) amine, S-
triazine molecules included in our moiety which have been described as under. 
SECTION-I : SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(5"-ARYL)-ISOXAZOLE-3"-YL]-PHENYLAMINO}-
6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY-
1,3,5-TRIAZINE.  
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SECTION : I 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL) – 
ISOXAZOLE – 3" – YL] - PHENYLAMINO} – 6 - [BIS (2"' - 
CHLOROETHYL)  AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
 Isoxazole derivatives reported to potent biological activities, taking into 
consideration of wide therapeutic activity of isoxazole derivatives. The synthesis of 2-
{4'-[(5"-aryl)-isoxazole-3"-yl]-phenyl amino}-6-[Bis(2"'-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine have been sythesised by the condensation of 2-{4'-[(3"-
aryl)2"-Propene-1"-one]-pheyl amino}-6-[Bis-(2"'-chloro ethyl) amino]-4- methoxy-
1,3,5- triazine with hydroxyl amine hydrochloride.  
R
O
NNCl
N
N
NCl
O
N
H
(Type-II) R = Aryl  
 The constitution of the products have been characterised by elemental 
analyses, IR, 
1
H NMR and Mass spectral study. The product were screened for 
antimicrobial activity at a concentration of 50 µg.  
 
 The details have been cited in the part : I, section : I, Page No. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[(5"-(4""-METHOXYPHENYL)-
ISOXAZOLE-3"-YL]-PHENYLAMINO}-6-[BIS(2"'-(CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Isoxazole 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C-N  Str. 
C=N  Str. 
N-O  Str. 
 
2956 
2875 
1421 
1363 
3060 
1168 
840 
1510 
1120 
1602 
3348 
1618 
1244 
1068 
769 
1190 
1602 
840 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1230-1020 
1650-1550 
850-810 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{5"-[(4""-METHOXYPHENYL)-
ISOXAZOLE-3"-YL]-PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL)  
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
 
Internal standard : TMS , Solvent : CDCl3 ,  Instrument : BRUKER spectrometer (300 MHz) 
 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
3.42-3.98 
7.35-7.99 
8.12-8.40 
4.05-4.19 
2.82-2.84 
10.19-10.28 
8.12-8.16 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
1 H 
Singlet 
D Doublet 
D Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-Hg 
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MASS SPECTRAL STUDY OF 2-{4'-[(5"-(4""METHOXY PHENYL)-ISOXAZOLE-3"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 515) 
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Antimicrobial Activity :  
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4-(22) 3-OH C6H4 (20) 3-OH C6H4 (21) 2-OH C6H4 (22) 4-OH C6H4 (22) 
 4-Br. C6H4 (22) 4-OH C6H4 (21) 4-OH C6H4 (22) 4-OH C6H4 (21) 4-OH C6H4 (21) 
  4-NO2 C6H4 (22) 4OH, 3OCH3 C6H3 
(20) 
4-OCH3 C6H4 (23) 4-Br C6H4 (23) 
   4-NO2 C6H4 (21) 4-NO2 C6H4 (24) 4-NO2 C6H4 (20) 
 
   Comparable activity with known standard drugs  
Ampicilin              50 µg. 23 18 17 27 - 
Chloramphenicol    ” 24 19 25 26 - 
Norfloxacin           ” 24 19 25 26 - 
Greseofulvin              ” - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
O
NNCl
N
N
NCl
O
N
H
NHCl
Cl
40 % Aq. NaOH
(Type-II) R = Aryl
NH2OH HCl
HCl
CH3COONa
RT , Methanol
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(5"-ARYL)-ISOXAZOLE-3"-YL]-PHENYL AMINO}-
6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetyl Phenyl amino)-4,6-dichloro-1,3,5-triazine.  
 For synthesis sec Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis fo 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"- chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis see Part-I, Section-I, Page no. : 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4-'"'-Methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis (2"'- chloro ethyl) amino]-4-methoxy-1,3,5 trizine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[5"-(4""-Methoxy phenyl)-isoxazole-3"-yl]-phenyl 
amino}-6-[Bis (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triaizine. (5.02 gm, 
0.01 M) hydroxy amine hydrochloride (0.69 gms., 0.01 M) and ethanol (20 
ml). The reaction mixture was reflux at 120º C. for 6 hrs. The reaction mixture 
was cooled, poured into crushed ice, filtered, dried. The isolated products was 
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crystallised from methanol. Yield 73% ; mp. 118º C. (Found : C : 55.89; H : 
4.61; N : 16.28, C24H24O3N6Cl2, required : C : 55.92; H : 4.66, N : 16.31%)   
       Simillary other isoxazols were synthesised and their physical data 
recorded in Table no. 3 
 
(F) Antimicrobial activity of 2-{4'-[5"-aryl)-isoxazole-3"-yl]-Phenyl amino}-6-
[Bis-(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 Antimicrobial testing was carried out as described in Part-I, Section-I, Page 
no. 39-41.  
 The zone of inhibition of the test solutions are recorded in Table no. 4  
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TABLE NO. : 3  PHYSICAL CONSTANT OF 2-{4'-[(5"-ARYL)-ISOXAZOLE-3"-YL]-PHENYL AMINO}-6-[BIS(2"-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
ºC 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C23H22Cl2N6O2 219 69 17.31 17.29 
2. 2-OH C6H4 C23H22Cl2N6O3 225 72 16.76 16.70 
3. 3-OH C6H4 C23H22Cl2N6O3 265 75 16.76 16.17 
4. 4-OH C6H4 C23H22Cl2N6O3 198 77 16.76 16.70 
5. 4-OCH3 C6H4 C24H24Cl2N6O3 118 73 16.31 16.28 
6. 4-OH, 3-OCH3 C6H3 C24H24Cl2N6O4 210 82 15.81 15.79 
7. 4-Br C6H4 C23H21BrCl2N6O2 209 87 14.89 14.83 
8. 3-NO2 C6H4 C23H21Cl2N7O4 264 81 18.49 18.47 
9. 4-NO2 C6H4 C23H21Cl2N7O4 202 83 18.49 18.45 
10 4-N,N-(CH3)2 C6H3 C25H27Cl2N7O2 173 79 18.55 18.51 
11. C4H3O (Furfuryl) C21H20Cl2N6O2 234 86 17.68 17.62 
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TABLE NO. 4 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL)-2"-ISOXAZOLE-3"-YL]PHENYLAMINO}-6-[BIS(2"-
CHLORO ETHYL)-AMINO]-4- METHOXY-1, 3, 5-TRIAZINE 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in 
mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5- 19 15 17 20 17 
2 2-OH C6H4- 17 17 18 22 19 
3 3-OH C6H4- 20 20 21 19 18 
4 4-OH C6H4- 22 21 22 21 22 
5 4-OCH3 C6H4- 18 19 19 23 21 
6 4-OH, 3-OCH3 C6H3- 19 18 20 18 16 
7 4-Br C6H4- 23 16 18 17 23 
8 3-NO2 C6H4- 16 17 19 16 17 
9 4-NO2 C6H4- 18 22 21 24 20 
10 4-N,N-(CH3)2 C6H3- 17 18 21 18 19 
11 C4H3O (Furfuryl)  19 17 18 16 15 
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PART - III 
STUDIES ON PYRAZOLINES 
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STUDIES ON PYRAZOLINES 
 
INTRODUCTION  
 Amongst nitrogen containing five membered heterocycles, pyrazolines (Q) 
have proved to be the most useful frame work for biological activities, pyrazolines 
have attracted attention of medicinal chemistry for both with regard to hererocyclic 
chemistry and the pharmacological activities associated with them in 1967. Jarobe 
reviewed the chemistry of pyrazolines, which have been studied extensively for 
their
132-133
 and industrial applications.  
N
H
N
(Q)  
SYNTHETIC ASPECT :  
 Different methods for the preparation of 2-pyrazoline derivatives documented 
in literature are as follows.  
(1) 2-pyrazolines can be constructed by the cyclocondensantion of chalcones with 
hydrazine hydrate.
134
 
R
R'
O
N
H
N
R
R'
NH2NH2 H2O+
 
(2) 2-Pyrazoline can also be prepared by the condensation of chalcone dibromide 
with hydrazines.
135
 
(3) 2-Pyrazolines can be synthesised by the cycloaddition of diazomethane to 
substituted chalcone.
136
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(4) Dipolar cycloaddition of intrilimines of dimethyl fumarate fumaronitrile and 
the N-aryl maleimides yields the corresponding pyrazolines.
137
 
(5) Epoxidation of chalcones have epoxy ketones which reacted with hydrazine 
and phenyl hydrazine to give pyrazolines.
138
 
 
 Further more, B. Gyassi et al.
139
 investigated the one pot synthesis of some 
pyrazolines in dry media under microwave irradiation. S. Paul et. al.
140
 A. Dandia et. 
al.
141
 have also described the microwave synthesis of 2-pyrazolines.  
 
MECHANISM :  
 The following mechanism seems to be operable for the condensation of 
chalcones with hydrazine hydrate.
142
 
 
 Nucleophilic attack by hydrazine at the -carbon of the unsaturated 
carbonyl system forms species (II) in which the-ve charge is mainly accomodated by 
the electro nagative oxygen atom. 
Proton transfer from the nitrogen to -ve oxygen produces an intermediate enol which 
simultaniously ketonise to ketoamine (III). Another intramolecular nucleophilic attack 
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by the primary amino group of ketoamine on its carbonyl carbon followed by proton 
transfer from nitrogen to oxygen leads ultimately to amine (IV). The later with by 
hydroxy group and amino group on the carbon lose water moleculer to yield the 
pyrazolines.  
THERAPEUTIC IMPORTANCE :  
 From the literature survey, it was reveled that 2-pyrazolines are better 
therapeutic agents,  
(a) Analgesic
143,144
 
(b) Bactericidal
145,146
 
(c)  Cardiovascular
147
 
(d) Diuretic
148
 
(e) Fungicidal
149
 
(f) Herbicidal
150
 
(g) Hypoglycemic
151
 
(h) Insecticidial
152
 
(i) Tranquilizer
153
 
(j) Antiallergic
154
 
(k) Anticonvalsant
155-156
 
(i) Antidiabetic
157
 
(m) Antiimplantation
158
 
(n) Antiinflamatory
159
 
(o) Antitumor
160
 
(p) Antineoplastic
161
 
(q) Antimicrobial
162
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S. S.  Sonarc et al.
163
 have synthesized 3-(2-acetoxy-4-methoxy phenyl)- 5-
(substituted phenyl)-pyrazolines(R) and tested their antimicrobial activity.  
NN
R
OACO
R''
R'
(R)  
Moreover, T. M. Stivenson et al.
164
 have also investigated N-substituted 
pyrazoline type insecticides. Katsuhori
165
 have patented pyrazoline derivatives as 
herbicides and K. Johannes, et. al.
166
 reported insecticides. Z. Moritaz and S. Hadol
167
 
to investigated a semiemperial molecular orbital study on the reaction of 
aminopyrazolinyl azo dye with singlet molecular oxygen.  
 
 
M. K. Shivnanda and co-worker
168
 have prepared pyrazolines and reported 
their antibacterial activity. B. Shivarama Holla et. al.
169-170
 have synthesised 
pyrazolines as antibacterial agent. S. P. Hiremath et al.
171
 have synthesised 
pyrazolines as analgesic, antiinflammatory and antimicrobial agent. V. Malhotra et. 
al.
172
 have synthesised new pyrazolines as a cardiovascular agent.  
 
 Ji-In Kim Almstead et. al.
173
 have prepared pyrazolines as vascularization 
agent. Guniz kucukguzel et. al.
174
 have synthesised pyrazolines as a antimicrobial and 
anticonvulsant agents.  
 
 T. Z. Gulhan and co-workers
175
 have prepared pyrazolines as a hypogxycemic 
agent. S. Sharma et. al.
176
 have synthesised pyrazolines and tested their 
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antiinflamatory activity. Ashok Kumar et. al.
177
 have synthesised pyrazolines as 
anticonvulsant agent.  
Contribution in our Laboratory :  
 D. M. Purohit  et. al.
131 
 have synthesised 2-(4'-chloro phenyl)-6-methyl-3-(3"-
aryl-4", 5"-dihydro-1"-H-pyrazole-5"-yl)-imidazo [1, 2-a] pyridine.  
N
N
NH
N
Cl
R
N
N
N
N
Cl
R
O
N
N
N
N
Cl
R
R = aryl  
SECTION-I :  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
(5"ARYL)4", 5"-DIHYDRO-1"-(H) PYRAZOL-3"-YL] 
PHENYL AMINO}-6-[BIS(2"'-CHLORO ETHYL)AMINO]-
4-METHOXY-1,3,5-TRIAZINE.  
 
SECTION-II : SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
[(5"-ARYL)-4", 5"-DIHYDRO-1"-ACETYL PYRAZOL-3"-
YL]-PHENYLAMINO}-6-[BIS. (2"'-CHLORO 
ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
SECTION-III :  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
[5"-ARYL]-4"-5"-DIHYDRO-1"-PHENYL PYRAZOL-3"-
YL]-PHENYL AMINO}-6-[BIS. (2"'-CHLORO ETHYL) 
AMINO]-4- METHOXY-1,3, 5- TRIAZINE.  
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SECTION : 1 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-(5"-ARYL)4", 5"-
DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL AMINO}-6-[BIS (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 Pyrazoline derivatives possess broad spectrum of pharmacological activities 
which are reflacted by their use as analgesic, anticonvulsant, antimicrobial, 
antipyratics agents. Prompted by above facts 2-{4'-(5"-aryl)4", 5"-dihydro-1"-(H) 
pyrazol-3"-yl] phenyl amino}-6-[Bis (2"'-chloroethyl) amino]-4-methoxy- 1,3,5- 
triazine Type-(III) have been synthesised by the condensation of 2-{4'-[(3"-aryl)-2"-
propene-1". one]-phenyl amino}-6-[Bis 2"'-chloroethyl) amino]-4-methoxy-1,3,5- 
trazine with hydrazine hydrate.  
R
NH
NNCl
N
N
NCl
O
N
H
(Type-III) R = Aryl  
 The constitution of the synthesized products were supported by IR, 
1
H, NMR 
and Mass spectral study. The products were screened for their antimicrobial activity at 
a concentration of 50 µg.  
 
The details have been cited in the Part : I, Section : I, Page No. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-(5"-(4””-METHOXYPHENYL)4", 5"-
DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL AMINO}-6-[BIS (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE.   
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
Ether 
 
Halide 
Pyrazoline 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=O  Str. 
C=N  Str. 
CH-CH2 Str. 
N-H  Str. 
 
2908 
2877 
1458 
1361 
3072 
1294 
823 
1458 
1168 
1616 
3373 
1245 
1037 
767 
1662 
1667 
2366 
3303 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1260-1220 
1075-1020 
800-600 
1705-1650 
1650-1550 
2850-1790 
3520-3140 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-(5"-(4""-METHOXYPHENYL)4", 5"-
DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL AMINO}-6-[BIS (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
 
Internal standard : TMS, Solvent : CDCl3 ,  Instrument : DPX-200 Spectrometer (300 MHz) 
 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
3.83-3.92 
7.20-7.22 
8.12-8.32 
4.02-4.06 
2.69-3.29 
10.15 
3.52-3.82 
 
6 H 
4 H 
4 H 
4 H 
4 H 
2 H 
2 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-CH2 h 
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MASS SPECTRAL STUDY OF 2-{4'-(5"-(4””-METHOXYPHENYL)4", 5"-DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL 
AMINO}-6-[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 516) 
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Antimicrobial Activity :  
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
  
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega.  
R 
B. subtillis  
R 
E. coli.  
R 
P. fluorescens.  
R 
A. awamori. 
R.  
 2-OH C6H4 (21) 3-OH C6H4 (18) 3-OH C6H4 (21) 2-OH C6H4 (21) C6H4 (21) 
 4-OH C6H4 (23) 4-OH C6H4 (19) 4-OH C6H4 (20) 4-OH C6H4 (23) 3-OH C6H4 (22) 
 4-Br C6H4 (22) 4-OH 3-OCH3 C6H3 (18) 4-Br. C6H4 (23) 4-OH, 3OCH3  
C6H3 (22) 
4-OCH3 C6H4 (23) 
  4-N,N (CH3)2 C6H4 (21) 4-NO2 C6H4 (20) 4-Br. C6H4 (22) 4-Br. C6H4 (21) 
 
   Comparable activity with known standard drugs  
Ampicilin  (50 µg.) 23 18 17 27 - 
Chloramphenicol  " 24 19 25 26 - 
Norfloxacin " 24 19 25 26 - 
Greseofulvin " -  - - 23 
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REACTION SCHEME 
 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NH
NNCl
N
N
NCl
O
N
H
(Type-III) R = Aryl
NH2NH2 H2O
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-(5"-ARYL)4", 5"-DIHYDRO-1"-(H) PYRAZOL-3"-YL] 
PHENYL AMINO}-6-[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-
1,3,5-TRIAZINE.  
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine 
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6- chloro-4-methoxy-1,3,5-
triazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl Phenyl amino)-6-[Bis-(2"-chloroethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4"'-methoxy phenyl)- 2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine.  
 For synthesis see Part-I, Section-I, Pagen no. 36-38. 
 
(E) Synthesis of 2-{4'-[5-'"(4""-methxoxy phenyl) 4", 5"-dihydro-1"-(H) - 
pyrazol - 3"-yl] phyenyl amino}-6-[Bis (2"'-chloroethyl) amino]-4-
methoxy-1,3,5- triazine.  
 
   A mixture of 2-{4'-[3"-(4""-methoxyphenyl)-2"-propene-1"-one] 
phenyl amino}-6-[Bis (2"'-chloroethyl) amino]-4-methxoxy-1,3,5-triazine 
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(5.02 gm, 0.01 M) hydrazine hydrate (1.0 ml) in methanol (15 ml) was 
refluxed for 12 hrs. The product was poured into crushed ice filtered, washed 
with water and crystallised from dixoane yield : 82%, M.P. 280° C. (Found : C 
: 55.80, H : 5.21, N : 18.97, C24H27O2N7Cl2; C : 55.81, H : 5.23, N : 18.99%) 
Simillarly other pyrazoleo derivatives have been synthesisded and their 
physical data are recorded in Table no. 5  
 
(F) Antimicrobial activity of 2-{4'-[(5''-aryl) 4", 5" - dihydro-1"-(H)-pyrazol-
3"-yl]-phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-
triazine  
 The antimicrobial testing was carried out as described in Part-I, Secton-I, Page 
no. 39-41.  
 The zone of inhibition of the test solution are recorded in Table no. 6. 
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TABLE NO :  5 PHYSICAL CONSTANTS OF 2-{4'-(5"-ARYL)4", 5"-DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL AMINO}-6-
[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C23H25Cl2N7O 207 70 20.16 20.11 
2. 2-OH C6H4 C23H25Cl2N7O2 249 72 19.52 19.50 
3. 3-OH C6H4 C23H25Cl2N7O2 225 75 19.52 19.51 
4. 4-OH C6H4 C23H25Cl2N7O2 198 79 19.52 19.48 
5. 4-OCH3 C6H4 C24H27Cl2N7O2 280 82 18.99 18.97 
6. 4-OH, 3-OCH3 C6H3 C24H27Cl2N7O3 268 81 18.41 18.40 
7. 4-Br C6H4 C23H24 Br Cl2N7O 205 69 17.34 17.32 
8. 3-NO2 C6H4 C23H24Cl2N8O3 242 83 21.09 21.08 
9. 4-NO2 C6H4 C23H24Cl2N8O3 188 89 21.09 21.05 
10 4-N,N(CH3)2 C6H4 C25H30Cl2N8O 216 71 21.16 21.12 
11. C4H3O (Furfuryl) C21H23Cl2N7O2 298(d) 77 20.58 20.57 
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TABLE NO : 6 ANTIMICROBIAL ACTIVITY OF 2-{4'-(5"-ARYL)4", 5"-DIHYDRO-1"-(H) PYRAZOL-3"-YL] PHENYL AMINO}-
6-[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
 
R 
Antibacterial activity 
Zone of inhibition in mm. 
 
Antifungal activity 
Zone of inhibition in 
mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 19 15 17 18 21 
2 2-OH C6H4 21 14 19 21 19 
3 3-OH C6H4 20 18 21 20 22 
4 4-OH C6H4 23 19 20 23 20 
5 4-OCH3 C6H4 18 16 22 19 23 
6 4-OH, 3-OCH3 C6H3 17 18 18 22 18 
7 4-Br C6H4 22 20 23 22 21 
8 3-NO2 C6H4 20 15 17 19 17 
9 4-NO2 C6H4 18 17 20 18 20 
10 4-N, N(CH3)2 C6H4 19 21 17 20 19 
11 C4H3O (Furfuryl) 17 16 18 19 20 
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SECTION : II 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL)-4", 
5"-DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-PHENYLAMINO}-6-[BIS. 
(2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 Acetyl pyrazoline dervatives procuring better therapeutic and antimicrobial 
activity looking at their better therapeutic importance and with an aim to getting better 
drug, it was considered worth while to synthesis some new pyrazoline. The synthesis 
of 2-{4'-[(5"-Aryl)-4", 5"-dihydro-1"-acetyl pyrazol-3"-yl]-phenyl amino}-6-[Bis(2"'-
chloro ethyl) amino]-4-methoxy -1,3,5-triazine of Type (IV) have been synthesised by 
the cyclocondensation of chalcones of Type (I) with hydrazine hydrate and glacial 
acetic acid.  
R
N
NNCl
N
N
NCl
O
N
H
O(Type-IV) R = Aryl  
 The constitution of the products have been characterised by elemental analyses 
IR, 
1
H NMR and Mass spectral study. The products were screened for their 
antimicrobial activity at a concentration of 50 µg.  
 
The details have been in the Part : I, Section I, Page No. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[(5"-(4""-METHOXYPHENYL)-4", 5"-
DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-PHENYLAMINO}-6-[BIS. (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyrazoline 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=O  Str. 
C=N  Str. 
CH-CH2 Str. 
 
2856 
2878 
1458 
1363 
3055 
1249 
838 
1458 
1068 
1600 
3452 
1647 
1271 
1033 
769 
1670 
1600 
1830 
 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1705-1650 
1650-1550 
2850-1790 
 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
”  
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'[(5"-(4""-METHOXYPHENYL)-4", 5"-
DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-PHENYLAMINO}-6-[BIS. (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
 
Internal standard : TMS ; solvent : DMSO ; Instrument : BRUKER Sepctrometer (300 MHz) 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.60-3.64 
7.44-7.72 
7.85-9.90 
4.57-4.60 
2.27-2.87 
9.73 
3.10-3.40 
2.87 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
3 H 
Singlet 
D Doublet 
D Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-CH2 h 
-COCH3 
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MASS SPECTRAL STUDY OF 2-{4'-[(5"-(4""-METHOXYPHENYL)-4", 5"-DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-
PHENYLAMINO}-6-[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 558) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
 
Antifungal activity 
Zone of inhibition 
in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4 (22) 2-OH C6H4 (28) 3-OH C6H4 (20) 2-OH C6H4 (21) 3-OH C6H4 (20) 
 4-OCH3 C6H4 (21) 3-OH C6H4 (19) 4-OH C6H4 (23) 4-OH C6H4 (23) 4-OH C6H4 (21) 
 4-OCH3, 3-OCH3 4-OH C6H4 (21) 4-OCH3 C6H4 (22) 4-OH, 3-OCH3–C6H3 (21) 4-Br C6H4 (22) 
 C6H3 (23) 4-Br C6H4 (22) 4-Br C6H4 (20)  - 
 4-Br C6H4 (22) 4-NO2 C6H4 (21) - C4H3O-(21) - 
 4-N,N(CH3)2 C6H4 (23) C4H3O (20)    
   Comparable activity with known standard drugs  
Ampicilin (50 g) 23 18 17 27 - 
Chloramphenicol  “ 24 19 25 26 - 
Norfloxacin          “ 24 19 25 26 - 
Greseofulvin           “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
N
NNCl
N
N
NCl
O
N
H
O
NaOCH3
(Type-IV) R = Aryl
CH3COOH
NH2NH2 H2O
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITYOF 2-{4'-[(5"-ARYL)-4", 5"-
DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-PHENYLAMINO}-6-[BIS. (2"'-
CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetylphenyl amino)-4, 5-dichloro-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
 (C) Synthesis of 2-(4'-Acetyl phenyl amino)-6- [Bis (2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
 (D) Syntesis of 2-{4'-[3"-(4""-methoxyphenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis (2"'-chloroethyl) amino]-4-methoxy 1,3,5-triazine.  
 For synthesis, Part-I, SectionI, Page No. 36-38. 
 
 (E) Synthesis of 2-{4'-[5"-(4""-methoxyphenyl)-4", 5"- dihydro-1"-(H)-
pyrazol-3"-yl]-phenylamino}-6-[Bis(2"'-chloro ethyl amino]-4-methoxy-
1,3,5-triazine.  
 A mixture of 2-{4'-[3"-(4""methoxyphenyl)-2" propene-1"-one] phenyl amino-
6-[Bis (2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine (5.02 gm, 0.01M); 
hydrazine hydrate (1.0 ml), glacial aceticacid (2.0 ml.)and methanol (20 ml) 
was refluxed for 12 hrs. The reaction mixture is poured into crushed ice, 
filtered, dried and crystallised from dioxane. Yield : 80%, M.P.: 168º C, 
(Found C : 55.90, H : 5.17; N : 17.54; C29H29O3Cl2N7 required C : 55.91; H : 
5.19, N : 17.56%)  
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Simillarly other acetyl pyrazoline have been synthesised and their physical 
constant are recorded in Table No.7)  
 
 (F) Antimicrobial activity of 2-{4'-[(5"-Aryl)-4", 5"- dihydro 1"-acetyl 
pyrazol-3"-yl]-phenyl amino}-6- [bis(2"'-chloro ethyl) amino]-4-methoxy-
1,3,5- triazine.  
 
The antimicrobial testing was carried out as described in Part : I, Section : , 
Page No. : 39-41. 
 The zone of inhibition of the test solution are recorded in Table No. : 8  
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TABLE NO : 7 PHYSICAL CONSTANTS OF 2-{4'-[(5"-ARYL)-4", 5"-DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-
PHENYLAMINO}-6-[BIS (2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C25H27Cl2N7O2 171 78 18.55 18.52 
2. 2-OH C6H4 C25H27Cl2N7O3 215 71 18.01 18.00 
3. 3-OH C6H4 C25H27Cl2N7O3 272 75 18.01 18.01 
4. 4-OH C6H4 C25H27Cl2N7O3 186 81 18.01 17.99 
5. 4-OCH3 C6H4 C26H29Cl2N7O3 168 80 17.56 17.54 
6. 4-OH 3-OCH3 C6H3 C26H29Cl2N7O4 235 79 17.07 17.05 
7. 4-Br  C6H4 C25H26BrCl2N7O2 227 82 16.14 16.12 
8. 3-NO2 C6H4 C25H26Cl2N8O4 280 84 19.54 19.50 
9. 4-NO2 C6H4 C25H26Cl2N8O4 256 87 19.54 19.51 
10 4-N,N(CH3)2 C6H4 C27H32Cl2N8O2 279 73 19.61 19.60 
11. C4H3O (furfuryl) C23H25Cl2N7O3 194 77 18.91 18.89 
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TABLE NO : 8  ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL)-4", 5"-DIHYDRO-1"-ACETYL PYRAZOL-3"-YL]-
PHENYLAMINO}-6-[BIS(2"'-CHLORO ETHYL)AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
Sr. 
No. 
Antibacterial activity 
Zone of inhibition in m.m. 
 
Antifungal activity 
Zone of inhibition 
in m.m. 
 B. mega. 
 
B. subtillis 
 
E. coli. 
 
P. fluorescens. 
 
A. awamori. 
C6H5 18 16 18 15 18 
2-OH C6H4 19 18 17 21 17 
3-OH C6H4 17 19 20 19 20 
4-OH C6H4 22 21 23 23 21 
4-OCH3 C6H4 21 17 22 20 16 
4-OH 3-OCH3 C6H3 23 16 19 22 18 
4-Br  C6H4 22 22 20 23 22 
3-NO2 C6H4 16 18 18 19 16 
4-NO2 C6H4 19 21 19 20 19 
4-N,N(CH3)2 C6H4 23 17 20 18 19 
C4H3O (furfuryl) 18 20 19 21 18 
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  SECTION-III 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL)-4"-5"-
DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL AMINO}-6-[BIS. (2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 Phenyl pyrazoline derivatives showes good therapeutic activities, it was 
considered worth while to synthesis compounds bearing 2-{4'-[(5"-aryl)-4", 5"-
dihydro-1"-phenyl pyrazol-3"-yl]-phenyl amino}-6-[Bis (2"'-chloroethyl) amino]-4-
methoxy-1,3,5-triazine of Type-(v) have been synthesised by the condensation of 2-
{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl amino}-6-[Bis(2"'-chloroethyl) amino -4- 
methoxy - 1,3,5-triazine of Type-(I) with phenyl hydrazine.  
R
N
NNCl
N
N
NCl
O
N
H
(Type-V) R = Aryl
 
 
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR, Mass spectral study. The products were screened for their antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the Part-I, Section-I, Page no. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[5"-(4""-METHOXYPHENYL]-4"-5"-
DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL AMINO}-6-[BIS (2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 
Instrument : SHIMADZU-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyrazoline 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C-N  Str. 
C=N  Str. 
CH-CH2 Str. 
 
2808 
2879 
1436 
1361 
3056 
1168 
823 
1458 
1037 
1600 
3396 
1600 
1251 
1068 
769 
1068 
1601 
2345 
 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1705-1650 
1650-1550 
2850-1790 
 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[5"-(4""-METHOXYPHENYL]-4"-5"-
DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL AMINO}-6-[BIS (2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 
Internal standard : TMS ; solvent : CDCl3 ; Instrument : BRUKER spectrometer (300 MHz) 
 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.80-3.90 
7.18-7.88 
7.97-8.25 
4.02-4.04 
2.67-3.27 
10.13 
7.97-8.12 
3.50 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
5 H 
2 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Multiplate 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
ArHg 
-CH2 h 
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MASS SPECTRAL STUDY OF 2-{4'--[5"-(4""-METHOXYPHENYL]-4"-5"-DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. (M.W. : 592) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
 
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4(21) 3-OH C6H4(18) 4-OH C6H4(21) 3-OH C6H4(22) C6H4(23) 
 4-OCH3 
C6H4(20) 
4-OH C6H4(19) 4-Br. C6H4(22) 4-OH C6H4(23) 4-OH C6H4(24) 
 4-Br. C6H4(22) 4-OH, 3-OCH3 C6H4(18) 3-NO2 C6H4(20) 4-Br C6H4(24) 3-NO2 C6H4(21) 
 4-NO2 C6H4(21) 4-Br C6H4(19) 4-NO2 C6H4(22) 4-NO2 C6H4(23) 4-NO2 C6H4(22) 
  4-NO2 C6H4(20)  4-N,N (CH3)2 C6H4(21)  
      
   Comparable activity with known standard drugs  
Ampicilin   50 g 23 18 17 27 - 
Chloramphenicol  ” 24 19 25 26 - 
Norfloxacin     ” 24 19 25 26 - 
Greseofulvin   ” - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
N
NNCl
N
N
NCl
O
N
H
(Type-V) R = Aryl
Ph-NH2NH2
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
SYNTHESIS OF 2-{4'-[5"-ARYL]-4"-5"-DIHYDRO-1"-PHENYL PYRAZOL-
3"-YL]-PHENYL AMINO}-6-[BIS (2"'-CHLORO ETHYL) AMINO]-4- 
METHOXY-1,3, 5- TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetyl pheyl amino)-4, 6-dichloro-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38.  
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis (2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-trizine  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[5"-(4""-Methoxyphenyl)-4", 5"- dihydro-1"-phenyl 
pyrazole-3"-yl]-phenyl amino} -6- [Bis (2"'-chloro ethyl) amino]-4- 
methoxy-1,3,5- triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis (2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine (5.02 gm, 
0.01M) phenyl hydrazine hydrate (1.0 ml) and methanol (20 ml) was refluxed 
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for 12 hrs. The reaction mixture was poured into crushed ice, filtered, washed 
with water and crystallised from dioxane. Yield : 78%, M.P. : 183° C. (Found 
C : 60.79, H : 5.21, N : 16.54, C30H31O2N7Cl2 required  C : 60.81, H : 5.23; N : 
16.55%)  
 Simillarly other phenylpyrazolines have been synthesised and their physical 
data are reocrded in Table No.9 
 
(F) Antimicrobial activity of 2-{4'[(5"-aryl)-4", 5"- dihydro-1" phenyl 
pyrazole - 3" - yl]-phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-
methoxy- 1,3,5- trizine.  
 
 The antimicrobied testing was carried out as described in Part-I, Section-I, 
Page no. 39-41.  
 The zone of inhibition of the test solution are recorded in Table No. 10 
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TABLE NO : 9 PHYSICAL CONSTANTS OF 2-{4'-[(5"-ARYL)-4"-5"-DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL 
AMINO}-6-[BIS (2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
°C 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C29H29Cl2N7O 218 78 17.43 17.41 
2. 2-OH C6H4 C29H29Cl2N7O2 249 81 16.95 16.92 
3. 3-OH C6H4 C29H29Cl2N7O2 258 76 16.95 16.91 
4. 4-OH C6H4 C29H29Cl2N7O2 197 83 16.95 19.93 
5. 4-OCH3 C6H4 C30H31Cl2N7O2 183 78 16.55 16.54 
6. 4-OH, 3-OCH3 C6H3 C30H31Cl2N7O3 205 79 16.11 16.09 
7. 4-Br. C6H4 C29H28BrCl2N7O 210 84 15.29 15.23 
8. 3-NO2 C6H4 C29H28Cl2N8O3 256 81 18.44 18.41 
9. 4-NO2 C6H4 C29H28Cl2N8O3 211 78 18.44 18.42 
10 4-N,N-(CH3)2 C6H4 C31H34Cl2N8O 278 85 18.50 18.48 
11. C4H3O (Furfuryl) C27H27Cl2N7O2 191 88 17.75 17.71 
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TABLE NO : 10  ANTIMICROBIAL ACTIVITY OF 2-{4'-[(5"-ARYL)-4"-5"-DIHYDRO-1"-PHENYL PYRAZOL-3"-YL]-PHENYL 
AMINO}-6-[BIS. (2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 18 14 16 17 19 
2 2-OH C6H4 17 12 18 19 23 
3 3-OH C6H4 19 18 19 22 21 
4 4-OH C6H4 21 19 21 23 24 
5 4-OCH3 C6H4 20 16 20 21 19 
6 4-OH, 3-OCH3 C6H3 16 18 19 20 17 
7 4-Br. C6H4 22 19 22 24 19 
8 3-NO2 C6H4 18 17 20 21 21 
9 4-NO2 C6H4 21 20 22 23 22 
10 4-N,N-(CH3)2 C6H4 17 16 18 21 19 
11 C4H3O (Furfuryl) 19 15 18 20 17 
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PART - IV 
STUDIES ON PYRIMIDINES 
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STUDIES ON PYRIMIDINES 
 
INTRODUCTION  
 Pyrimidine derivatives occur in natural products
179
 like nucleic acid and 
vitamin-B have remarkable pharmaceutical importance because of their biological
180-
183
 several analogs of nucleic acids have been used as compound that interfere with 
the synthesis and functioning of uncleic acids, and example is fluorouracil which has 
been used in cancer treatment. Pyrimidines are among those molecules that make life 
possible as being same of the building blocker of DNA and RNA.  
 
 Some pyrimidines of physiologically as well as pharmacologically importance 
are as under : e.g. cytosine, beclmeihrin(S), blasticidin(T).  
N
N
NH
2
OH
O
(S) N
O
N
O
N
H
O NH
2
NH
NH
2
OHO
(T)
 
 Synthetic pyrimidine derivatives contribute much to the searchable literature 
of pyrimidine derivities, in huge libraries owing to their wide applicability in different 
fields.  
 
SYNTHETIC ASPECT :  
 Different methods for the synthesis of pyrimidine have been cited in the 
literature.
184
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1. F. Bigi and co-worker
185
 have synthesised as shown below under solvent free 
condition.  
N
H
N
H
OO
O
NH
2
O
NH
2
O
O
O
O
HCl
 
REACTION MECHANISM :  
 The reaction of , -unsaturated system with urea to the formation of 4-oxo-
pyrimidine by 1, 2 and 1, 4 michal addition.  
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THERAPEUTIC IMPORTANCE  
 Pyrimidine derivatives have proven to be of great importance in exhibiting and 
enhancing the biological activities such as.  
(a) Antitumor
186
 
(b) Carcinostatic
187
 
(c) antiinflammatory and anticonvulsant
188-189
 
(d) Antimalarial
190
 
(e) Antithyroid
191
 
(f) Anthelmintic
192
 
(g) Anti-HIV
193-194
 
(h) Antilishmenial
195
 
(i) Antiviral
196
 
(j) Antimicrobial
197
 
(k) Herbicidal
198-204
 
(l) Antagonists
205-209
 
 Moreover, L. V. Azarayan et al.
210
 have synthesised pyrimidine diones as 
antitumor agent. V. P. Krivongov and co-worker
211
 have synthesised pyrimidinone 
derivatives possessing immunotropic and antiinflammatory activity. M. Refai and co-
worker
212
 have prepared some new pyrimidine derivatives showed moderate activity 
against the growth of Bacillus substilis, staphylococus aureus and Aspergillus niger. 
A. Kofies et. al.
213
 have seggested that pyrimidinone (U)(V) as herbicidal and plant 
growth regulators.  
N
N
H
O
O
R
R'
(U)
N
NCF
3
O
F Cl
O
(V)
R = alkyl
R' = H, halogen  
 K. Mogilaiash
214
 have  prepared spiro pyrimidinones as antibacterial.                    
M. wilhelm
215
 have synthesised pyrimidinones as herbicidal agents.  
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 C. D. Timothy and co-worker
216
 have suggested imidazolyl pyrimidinones as 
antiviral T. Nagamatsu et. al.
217
 have prepared some new triazolo [3,4-c] pyrimidine 
as xanthin oxidase inhibitors. A. Roland et. al.
218
 have prepared oxazolyl uracil as 
herbicidal and insecticidal. M. M. Yari and co-worker
219
 have investigated the 
pyrimidinone derivatives which possess caclcium antagonist activity.  
 M. A. Bruce and co-worker
220
 prepared the dihydro pyrimidinones as NPY 
antagonist.  
NH
N
H
NH
2
O
O
O
 
 D. R. Sidler
221
 have reported pyrimidinone derivatives, useful as an - 
adrenergic receptor antagonist.  
N
H
NH
F
F
O
O
O
O
 
 Mona Mahram and co-worker
222
 have synthesied pyrimidine derivatives as 
potent antimicrobial and antitumor agents.  
 K. A. Gupta and co-worker
223
 have prepared 2,6-disubstituted pyrimidinones 
as CNS agent.  
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N
O
R R'
R = alkyl, aryl
R' = alkyl, aryl
 
 Pyrimidinone derivatives
224-225
 have found to be calcium channel blocker.       
M. M. Barbuliene et. al.
226
 have synthesised pyrimidione as antiinflammatary agent.  
NH
N
H
O
O
O
O
NH
N
H
O
OR
O
 
 Recently. Amjad Ali et. al.
227
 have synthesised new fused pyrimidinones as 
antimicrobial agents. Abd El-Galil et. al.
228
 have synthesised pyrimidine as 
androgenic, anabolic and antiinflammatory agents. Martin Bolli et. al.
229
 have 
synthesised pyrimidines as endothelin receptor antagonists. G. Z. Hang et. al.
230
 have 
synthesised and screened for their leukocyte functions inhibitor activity. Yam amoto 
et al.
231
 have synthesised pyrimidines and tested their hyderproliferative disorder 
activity. V. N. Patolia et al.
232
 have been synthesised 2-{4'[6''(aryl)-2-
''hydroxy,3'',4''dihydro pyrimidine-4''-yl]-phenyl amino}-4,6-dimethoxy pyrimidines 
and screened their antimicrobial acivity.  
N
H
N
N
N
O
O N
H
R
OHR = aryl
 
The synthesis of pyrimidines derivatives described as under. 
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SECTION : I  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-           
[(6"-ARYL-2"-MERCAPTO,3"-4"-DIHYDRO)-PYRIMIDINE-
4"-YL]-PHENYLAMNIO}-6-[BIS(2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
SECTION : II SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4- 
[(6"-ARYL-2"-HYDROXY-3",4"-DIHYDRO)-PYRIMIDNE-4"-
YL]-PHENYLAMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-
4-METHOXY-1,3,5-TRIAZINE.  
SECTION: III SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-           
[6"-ARYL-2"-AMINO-3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-
PHENYLAMINO}-6-[BIS(2"'-CHLOROETHYL)AMINO]-4-
METHOXY-1,3,5-TRIAZINE.  
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SECTION-I 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL-2"-
MERCAPTO-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 Pyrimidine nucleus possess remarkable pharmaceutical and biological 
activites. This valid observation lead us to synthesised 2-{4'-[(6"-aryl-2"-mercapto-3", 
4"-dihydro)-pyrimidine-4"-yl]-phenyl amino}-6-[Bis (2"'-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine of Type-(VI) have been condensation by the reaction of 
chalcones of Type-(I) with thiourea in the presence of alcoholic potassium hydroxide.  
R
NCl
N
N
NCl
O
N
H
N
N
H
SH(Type-VI) R = Aryl  
 The constitution of the products have been characterised by elemental analyses 
IR, 
1
H NMR, Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 The details have been cited in the part : I, section : I, page no. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[6"-(4""-METHOXYPHENYL-2"-
MERCAPTO-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL)  AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Thio Pyrimidine 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=S  Str. 
2905 
2877 
1458 
1357 
3031 
1170 
810 
1508 
1035 
1539 
3350 
1539 
1222 
1068 
769 
1571 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1590-1550 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
 104 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
NMR SPECTRAL STUDY OF 2-{4'-[6"-(4""-METHOXYPHENYL-2"-
MERCAPTO-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Internal standard : TMS;  solvent : CDCl3  ; Instrument : BRUKER spectrometer (300 MHz) 
 
Signal 
No. 
Signal 
Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.54-3.72 
7.52-7.78 
7.80-7.95 
4.65-4.68 
2.95-3.18 
9.81 
2.35 
7.71-7.74 
 
6 H 
4 H 
4 H 
4 H 
4 H 
2 H 
1 H 
1 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
ArSHg 
-Ar h 
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MASS SPECTRAL STUDY OF 2-{4'-[6"- [(4""-METHOXYPHENYL-2"-MERCAPTO-3"-4"-DIHYDRO)-PYRIMIDINE-4"-YL]-
PHENYL AMNIO}-6-[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 560) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
  
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega.  
R 
B. subtillis  
R 
E. coli.  
R 
P. fluorescens.  
R 
A. awamori. 
R 
 3-OH C6H4 (23) 3-OH C6H4 (18) 4-OH C6H4 (24) C6H5 (23) 3-OH C6H4 (23) 
 4-OH C6H4 (23) 4-OH C6H4 (19) 4-OH, 3-OCH3 3-OH C6H4 (24) 4-Br C6H4 (21) 
 4-Br. C6H4 (22) 4-Br. C6H4 (20) C6H3 (22) 4-OH C6H4 (24) 4-NO2 C6H4 (22) 
 3-NO2 C6H4 (24) 4-NO2 C6H4 (19) 4-Br C6H4 (23) 4-Br. C6H4 (23)  
  C4H3O (20) 4-NO2 C6H4 (21)   
      
   Comparable activity with known standard drugs  
Ampicilin 50 g 23 18 17 27 - 
Chloramphenicol  “ 24 19 25 26 - 
Norfloxacin         “ 24 19 25 26 - 
Greseofulvin          “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H
N
N
H
SH
NH
2
NH
2
S
(Type-VI) R = Aryl
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(6"-ARYL-2"-MERCAPTO-3",4"-DIHYDRO)-
PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro - 1, 3, 5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine  
 For syntesis Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis (2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Pagen no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis (2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[6"-(4""-methoxy phenyl)-2"-mercapto- 3", 4"-
dihydro-Pyrimidine-4"-yl]-phenyl amino}-6-[Bis (2"'-chloro ethyl) 
amino]-4-methoxy - 1, 3, 5, triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)-2"- propene-1"-one] phenyl 
amino}-6-[Bis (2"'-chloro ethyl) amino} -4- methoxy-1,3,5-triazine (5.02 gm, 
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0.01 M); and thiourea (0.66 gm, 0.01 M) was refluxed at 90° C for 13 hrs. in 
the presence of basic medium like alcoholic KOH and methanol. The reaction 
mixture was poured into crushed ice, filtered and dried. The product was 
isolated and crystallised from dioxane yield : 70%. m.p. : 171° C. (Found C : 
53.54; H : 4.81; N : 17.45; C25H27O2N7Cl2S required C: 55.57, H : 4.82, N : 
17.49%) 
  
 Simillarely other compounds were prepared and their physical data are 
recorded in Table No. 11  
 
(F) Antimicrobial activity of 2-{4'-[(6"-aryl-2"-mercapto-3", 4"-dihydro)-
pyrimidine-4"-yl]-phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-
methoxy-1,3,5- triazine.  
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page no. 39-41. 
 The zone of inhibition of the test solution are recorded in Table no. 12.  
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TABLE NO : 11 : PHYSICAL CONSTANTS OF 2-{4'-[(6"-ARYL-2"-MERCAPTO, 3"-4"-DIHYDRO)-PYRIMIDINE-4"-YL]-  
PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C24H25Cl2N7OS 218 77 18.48 18.41 
2. 2-OH C6H4 C24H25Cl2N7O2S 180 81 16.09 16.07 
3. 3-OH C6H4 C24H25Cl2N7O2S 138 83 16.09 16.05 
4. 4-OH C6H4 C24H25Cl2N7O2S 265 78 16.09 16.01 
5. 4-OCH3 C6H4 C25H27Cl2N7O2S 171 70 17.49 17.45 
6. 4-OH, 3-OCH3 C6H3 C25H27Cl2N7O3S 228 73 17.01 17.00 
7. 4-Br C6H4 C24H24BrCl2N7OS 272 82 16.09 16.02 
8. 3-NO2 C6H4 C24H24Cl2N8O3S 236 85 19.47 19.42 
9. 4-NO2 C6H4 C24H24Cl2N8O3S 157 87 19.47 19.44 
10. 4-N,N(CH3)2 C6H4 C26H23Cl2N8OS 183 79 19.54 19.50 
11. C4H3O (Furfuryl) C22H23Cl2N7O2S 226 76 18.48 18.43 
 
 111 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
TABLE NO : 12 ANTIMICROBIAL ACTIVITY OF 2-{4'-[6"-(ARYL-2"-MERCAPTO-3"4"-DIHYDRO)PYRIMIDINE-4”-YL]-
PHENYL AMINO}-6-[BIS (2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3, 5- TRIAZINE. 
 
Sr. 
No. 
 Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition 
in mm. 
 R B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 21 14 18 23 17 
2 2-OH C6H4 20 13 19 22 19 
3 3-OH C6H4 23 18 20 24 23 
4 4-OH C6H4 23 19 24 24 20 
5 4-OCH3 C6H4 19 16 17 20 18 
6 4-OH, 3-OCH3 C6H3 17 15 22 19 16 
7 4-Br C6H4 22 20 23 23 21 
8 3-NO2 C6H4 24 18 18 19 19 
9 4-NO2 C6H4 21 19 21 21 22 
10 4-N, N(CH3)2 C6H4 20 18 20 19 18 
11 C4H3O (Furfuryl) 19 20 18 16 17 
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SECTION : II 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL)2"-
HYDROXY-3",4"-DIHYDRO-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 Pyrimidine derviatives showed wide range of application in the field of 
pharmaceutical, it was considered worth while to synthesis compounds bearing S-
triazine, Bis (2-chloro ethyl) amine nucleus linked to pyrimidine nucleus. 2-{4'-[(6"-
aryl-2"-hydroxy-3", 4"-dihydro)-pyrimidine-4"-yl]-phenyl amino}-6-[Bis(2"'-chloro 
ethyl) amino]-4-methoxy -1,3,5-triazine of type(VII) have been synthesised by the 
condensation of 2-{4'-[(3"-aryl)-2"- propene-1"-one]-phenyl amino}-6-[Bis(2"'-chloro 
ethyl) amino]-4-methoxy-1,3,5-triazine of Type-(I) with urea in presence of catalytic 
amount of conc. HCl 
R
NCl
N
N
NCl
O
N
H
N
N
H
OHR = Aryl(Type-VII)  
 The constituion of the products have been characterised by elemental analyses 
IR, 
1
H NMR,  Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the part : I, Section I, Page NO. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[6"-(4''''-METHOXYPHENYL)-2"-
HYDROXY-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophotometer; frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed Reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Oxy Pyrimidine 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=O  Str. 
2835 
2880 
1458 
1363 
3036 
1168 
823 
1458 
1122 
1595 
3368 
1635 
1222 
1068 
769 
1654 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1650-1550 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[6"-(4''''-METHOXYPHENYL)-2"-
HYDROXY-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
Internal standard : TMS; solvent : DMSO ;  Instrument : DPX-200 spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.82-3.92 
7.22-7.99 
8.03-8.32 
4.02-4.06 
2.69 
10.06-10.15 
9.64 
7.99 
 
6 H 
4 H 
4 H 
4 H 
4 H 
2 H 
1 H 
1 H 
Singlet 
D Doublet 
D Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-OHg 
-Ar h 
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MASS SPECTRAL STUDY OF 2-{4'-[6"-(4''''-METHOXYPHENYL)-2"-HYDROXY-3",4"-DIHYDRO)-PYRIMIDNE-4"-YL]-
PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 544) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
  
Antifungal activity  
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 2-OH C6H4(23) 3-OH C6H4(18) C6H5(18) 3-OH C6H4(23) 2-OH C6H4(20) 
 4-OH C6H4(24) 4-OH C6H4(19) 3-OH C6H4(19) 4-OH C6H4(23) 4-OH C6H4(22) 
 4-Br C6H4(22) 4-OCH3 C6H4(18) 4-OH C6H4(22) 4-Br C6H4(22) 3-NO2 C6H4(21) 
 4-NO2 C6H4(23) 4-NO2 C6H4(19) 3-NO2 C6H4(20) 4-NO2 C6H4(24)  
  4-N,N(CH3)2 C6H4(20)    
      
   Comparable activity with known standard drugs  
Ampicilin   50 µg 23 18 17 27 - 
Chloramphenicol   “ 24 19 25 26 - 
Norfloxacin           “ 24 19 25 26 - 
Greseofulvin            “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H
N
N
H
OH
NH
2
NH
2
O
R = Aryl(Type-VII)
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPRIMENTAL 
 
SYNTHESIS OF 2-{4'-[(6"-ARYL-2"-HYDROXY-3",4"-DIHYDRO)-
PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6- chloro-4-methoxy-1,3,5-
triazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis. (2"chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For syntheis see Part-I, Section-I, Page no. 36-38. 
 
(D) Syntheis of 2-{4'-[3" -(4"'-Methoxy phenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-riazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[6"-(4""-Methoxy phenyl)-2"-hydroxy-3", 4"-dihydro)-
pyrimidine-4"-yl]-phenyl amino}-6-[Bis.(2"'-chloroethyl) amino]-4-
methoxy-1,3,5- triazine.  
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 A mixture of 2-{4'-[3"-(4"'-methoxy phenyl)-2"-Propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine (5.02 gm, 
0.01 M) and urea (0.60 g, 0.01 M) was refluxed at 90º C. for 12 hrs. in 
presence of acid catalyst like HCl in methanol the reaction mixture was 
poured into crushed ice, filtered and dried the product was isolated, 
crystallised from dioxane. Yield : 78%. M.P. 110º C. (Found : C : 55.11; H : 
4.95; N : 17.99; C25H27O3N7Cl2 required C : 55.14; H : 4.96; N : 18.01%) 
  Simillarly other pyrimidine derivatives have been synthesised and their 
physical data are recorded in Table no. 13.  
 
(F) Antimicrobial activity of 2-{4'[(6"-Aryl-2"-hydroxy, 3", 4"-dihydro)-
Pyrimidine - 4"-yl] phenyl amino}-6-[Bis.(2"'-chloro ethyl) amino]-4-
methoxy-1,3,5 triazine.  
 The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page no. 39-41.  
 The zone of inhibition of the test solutions are recorded in Table no. 14. 
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TABLE NO : 13 : PHYSICAL CONSTANTS OF 2-{4'-[(6"-ARYL-2"-HYDROXY-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL 
AMINO}-6-[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C24H25Cl2N7O2 180 81 19.06 19.03 
2. 2-OH C6H4 C24H25Cl2N7O3 228 79 18.48 18.41 
3. 3-OH C6H4 C24H25Cl2N7O3 262 83 18.48 18.43 
4. 4-OH C6H4 C24H25Cl2N7O3 280 85 18.48 18.47 
5. 4-OCH3 C6H4 C25H27Cl2N7O3 110 78 18.01 17.99 
6. 4-OH, 3-OCH3 C6H4 C25H27Cl2N7O4 192 76 17.49 17.43 
7. 4-Br. C6H4 C24H24BrCl2N7O2 224 79 16.53 16.51 
8. 3-NO2 C6H4 C24H24Cl2N8O4 265 81 20.03 20.01 
9. 4-NO2 C6H4 C24H24Cl2N8O4 249 84 20.03 20.02 
10 4-N,N(CH3)2 C6H4 C26H30Cl2N8O2 213 79 20.10 20.08 
11. C4H3O (Furfuryl) C22H23Cl2N7O3 211 83 19.44 19.41 
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TABLE NO : 14 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL-2"-HYDROXY-3",4"-DIHYDRO)-PYRIMIDNE-4"-YL]-
PHENYL AMINO}-6-[BIS (2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
Sr. 
No. 
 Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in 
mm. 
 R B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 20 12 18 15 19 
2 2-OH C6H4 23 14 17 19 20 
3 3-OH C6H4 21 18 19 23 19 
4 4-OH C6H4 24 19 22 23 22 
5 4-OCH3 C6H4 19 18 16 20 18 
6 4-OH, 3-OCH3 C6H4 17 16 15 18 17 
7 4-Br. C6H4 22 15 17 22 19 
8 3-NO2 C6H4 18 17 20 21 21 
9 4-NO2 C6H4 23 19 16 24 20 
10 4-N1N(CH3)2 C6H4 19 20 17 16 16 
11 C4H3O (Furfuryl) 17 16 14 21 18 
 122 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
SECTION : III 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[6"-ARYL-2"-
AMINO-3",4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYLAMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 Looking to the interesting pharmacological and agricultral activity of 
pyrimidine ring system it was considered worth while to synthesis compound being 
Bis (2-chloro ethyl) amine and S-triazine nucleus linked to the pyrimidime nucleus 2-
{4'-[6"-Aryl-2"-amino-3", 4"-dihydro)-pyrimidine-4"-yl] phenyl amino]-6-[Bis(2"'- 
chloroethyl) amino]-4- methoxy-1,3,5-triazine of Type (VIII) have been synthesised 
by the condensation of 2-{4'-[(3"-aryl)--2"-propene - 1" - one]- phenyl amino}-6-[Bis 
(2"'-chloroethyl) amino-4-methoxy-1,3,5-triazine of Type (I) with guanidine 
hydrochloride in the presence of alcoholic potassium hydroxide.  
R
NCl
N
N
NCl
O
N
H
N
N
H
NH
2(Type-VIII) R = Aryl  
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR,  Mass spectral study. The products were screened for antimicrobial 
acivity at a concentration of 50 µg.  
 
 The details have been cited in the Part : I, Section : I, Page No. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[6"-(4''''-METHOXYPHENYL)-2"-AMINO-
3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophotometer; frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed Reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Amino Pyrimidine 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
N-H Str. 
C=N  Str. 
C-N  Str. 
 
2925 
2876 
1460 
1355 
3081 
1180 
806 
1473 
1141 
1589 
3407 
1589 
1247 
1068 
767 
3350 
1616 
1116 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
3350-3250 
1612-1550 
1220-1020 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[6"- [4''''-METHOXYPHENYL)-2"-
AMINO-3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Internal standard : TMS; solvent : DMSO :  Instrument : DPX-200 spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.50-3.69 
7.49-7.90 
7.92-9.27 
4.62-4.65 
2.32-2.92 
9.69 
9.78 
7.49-7.52 
 
6 H 
4 H 
4 H 
4 H 
4 H 
2 H 
2 H 
1 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-NH2 g 
-Ar h 
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MASS SPECTRAL STUDY OF 2-{4'-[6"- (4''''-METHOXYPHENYL)-2"-
AMINO-3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 
543) 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H
N
N
H
NH
2
Type-VIII (R = Aryl)
Guanidine HCl
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4-(24) 3-OH C6H4-(19) 3-OH C6H4-(21) 2-OH C6H4-(24) 4-OCH3 C6H4-(20) 
 4-NO2 C6H4-(23) 4-OH C6H4-(20) 4-OCH3 C6H4-(20) 4-OH C6H4-(23) 4-Br C6H4-(22) 
 4-N,N (CH3)2  4-NO2 C6H4-(22) 4-Br C6H4-(22) 4-NO2 C6H4-(22) 4-NO2 C6H4-(21) 
 C6H4-(21)  4-N,N(CH3)2 C6H4-
(23) 
4-N,N(CH3)2 C6H4-
(23) 
4-N,N (CH3)2 C6H4-(20) 
     C4H3O(22) 
 
Comparable activity with known standard drugs 
Ampicilin        50 µg. 23 18 17 27 - 
Chloramphenicol    ” 24 19 25 26 - 
Norfloxacin           ” 24 19 25 26 - 
Greseofulvin            ” - - - - 23 
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(6"-ARYL-2"-AMINO-3", 4"-DIHYDRO)-
PYRIMIDINE-4"-YL]-PHENYL AMINO}-6-[BIS(2"'-CHLORO ETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
(A) Syntesis of 2-(4'-Acetyl phenyl amino)-4,6'-dichloro-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4"-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-
triazine.  
 For synthesis, See Part-I, Section-I, Page No. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"- chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(D)  Synthesis of 2-{4'-(3"-(4"'-Methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis, See Part-I, Section-I, Page no. 36-38.  
 
(E) Synthesis of 2-{4'-[6"-(4""-Methoxy phenyl)-2"-amino-3",4", dihydro-
pyrimidine-4"-yl]-phenyl amino}-6-[Bis(2"'-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
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 A mixture of 2-{4'-[3"-(4"'-methoxyphenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis. (2"'-chloroethyl) amino]-4- methoxy-1,3,5-triazine (5.02 gm., 
0.01 M) and guanidine hydrochloride (0.95 g, 0.01M) was refluxed at 110º C 
for 12 hrs. in presence of alcoholic KOH in methanol. The reaction mixture 
was poured into crushed ice filtered, dried and crystallised from dioxne. Yield 
: 80%. M.P. : 153º C (Found : C : 55.21; H : 5.13; N : 20.61; C25H28O2N8Cl2, 
required C: 55.24; H : 5.15; N : 20.62%).  
  Simillarly other pyrimidines were synthesised and their physical data 
are recorded in Table no. 15 
 
(F) Antimicrobial activity of 2-{4'-[(6"-aryl - 2"-amino-3", 4"-dihydro)-
pyrimidine-4"-yl]-phenyl amino}-6-[Bis-(2"'-chloroethyl) amino]-4- 
methoxy-1,3, 5,-triazine.  
 
 Antimicrobial testing was carried out as described in part : I, section : I, Page 
no. 39-41.  
 The zone of inhibition of the test solutions are recordeds in Table No. 16 
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TABLE NO : 15 : PHYSICAL CONSTANTS OF 2-{4'-[(6"-ARYL-2"-AMINO-3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C24H26Cl2N8O 189 78 21.82 21.80 
2. 2-OH C6H4 C24H26Cl2N9O2 180 81 21.16 21.14 
3. 3-OH C6H4 C24H26Cl2N8O2 212 69 21.16 21.15 
4. 4-OH C6H4 C24H26Cl2N8O2 239 73 21.16 21.13 
5. 4-OCH3 C6H4 C25H28Cl2N8O2 153 80 20.62 20.61 
6. 4-OH, 3-OCH3 C6H3 C25H28Cl2N8O3 149 72 20.03 20.01 
7. 4-Br. C6H4 C24H25BrCl2N8O 264 79 18.92 18.99 
8. 3-NO2 C6H4 C24H25Cl2N9O3 253 81 22.57 22.56 
9. 4-NO2 C6H4 C24H25Cl2N9O3 211 83 22.57 22.55 
10 4-N1N(CH3)2 C6H4 C26H31Cl2N9O 236 78 22.65 22.62 
11. C4H3O (Furfurl) C22H24Cl2N8O2 197 77 22.26 22.21 
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TABLE NO : 16 :ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL-2"-AMINO-3", 4"-DIHYDRO)-PYRIMIDINE-4"-YL]-
PHENYL AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 20 12 18 21 15 
2 2-OH C6H4 22 14 17 24 14 
3 3-OH C6H4 18 19 21 20 18 
4 4-OH C6H4 24 20 19 23 19 
5 4-OCH3 C6H4 18 15 20 18 20 
6 4-OH, 3-OCH3 C6H3 17 17 16 17 17 
7 4-Br. C6H4 19 16 22 19 22 
8 3-NO2 C6H4 20 18 19 16 18 
9 4-NO2 C6H4 23 22 18 22 21 
10 4-N,N(CH3)2 C6H4 21 18 23 23 20 
11 C4H3O (Furfuryl) 16 17 19 16 22 
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PART - V 
STUDIES ON CYANOPYRIDINES 
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STUDIES ON CYANOPYRIDINES 
 
INTRODUCTION  
 Pyridine and its derivatives represent one of the most active class of 
compounds possessing a wide spectrum of biological activities in the field of 
medicine, agriculture and industrial chemistry. Pyridine-3-carboxamide occurs as a 
component of the structure of the important coenzymes NADP +, one of the B12 
complex of vitamins, occurs in red blood corpuscles and participates in biochemical 
redox reaction. Pyridoxol (Vitimin B6) (I) Occurs in yeast and wheatgerm is an 
important food additive.  
N
OH
OH
OH
(I)  
The availability of 3-cyanopyridine, nicotinamide and nicotinic acid make possible 
their use as synthetic intermediates.  
 Most derivatives are prepared by manipulation of pyridine and its simple 
homologues in a manner similar to chemistry of the benzenoid chemistry. However 
the simple pyridine compounds are prepared by the cyclisation of aliphatic raw 
material.  
SYNTHETIC ASPECTS  
 Preparation of 3-cyanopyridines have been cited in literature 
233-237
 with 
different methods. The well known method is :  
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1. A.Samour and co-workers
238
 have prepared substituted cyanopyridines by the 
condensation of chalcones with malononitrile in presence of ammonium acetate.  
R
R'
O CH2(CN)2
CH3COONH4 N
R'
NH
2
R
CN
(II)  
MECHANISM  
 The mechanism for the condensation of chalcones with malononitrile is shown 
as under.  
 
 The reaction proceeds through conjugated addition of active methylene 
compounds to the ,  unsaturated system. The , -unsturated compound is known 
as acceptors and active methylene compound are known as following therapeutic 
activity.  
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THERAPEUTIC IMPORTANCE  
Cyanopyridines possess wide therapeutic activities listed as under.  
1. Antihypertensive
239
 
2. Antisoriasis
240
 
3. Antiepileptic
241
 
4. Anticonvulsant
242
 
5. Antifungal
243
 
6. Antibacterial
244
 
7. Herbicidal
245
 
8. Antiinflammatory
246
 
9. Anti HIV
247
 
 S. S. Verma et al.
248
 have synthesised 2-amino-3-cyano-2, 6-disubstituted 
pyridines and studied their biological activities. The insecticidal activity of 
cyanopyridines has been investigated by Y. Sosaki
249
, I. Teu and coworkers
250
 have 
shown cyanopyridines as agrochemical fungicides. M. Hussans and co-workers
251
 
have prepared 3-cyanopyridines and reported their pharmacological activity. S. Guru 
evaluated
252
 cyanopyridine derivatives (III) have been documented for their multiple 
biological activities.  
N
O
N
O
R
NH
2
NC (III)  
 F. Manna and co-workers
253
 have reported the antiinflammatory activity of 3-
cyanopyridines. Some new 3-cyanopyridine derivatives have been found to show 
anticancer and anti HIV activity.
254
 A. R. Parikh et al.
255-256
 have prepared some new 
cyanopyridines and studied their antimicrobial activity.  
 U. D. Pyachenko and co-workers
257
 have synthesised some cyanopyridine 
derivatives (IV) which are useful in the treatment of retroviral diseases. 
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Cyanopyridine derivatives (V) showing significant biological activity are 
described
258
.  
N
Se
NH
2
CN
NC
(IV)
N
NH
2
O
NC
(V)
 
 H. H. Parekh et al.
259
 have prepared new cyanopyridines and all products have 
been evaluated for their in vitro growth inhibitory activity against different microbes. 
T. B. Lowinger et al.
260
 have prepared some new cyanopyridines and postulated them 
as vitro and cellular activities.  
 
 Moreover, H. Hiroki et al.
261
 synthesised  2-acylamino-3, 5-dicyanopyridine 
derivatives useful as calcium channel opening drugs. Antimicrobial activity of 
cyanopyridine derivatives have reported by M. M. Komal
262
, E. B. Villhauer et al.
263
 
have prepared novel cyanopyridines which has been found to be bioactive dipeptidyl 
peptidase inhibitors.  
 
 The synthesis of cyanopyridines is of current interest owing to their bi 
dynamic occurence in biologically active derivatives. Hence, considerable attention 
has been focused on the study of efficient and pharmaceutically important 
cyanopyridines bearing Bis (2-chloroethyl) amine and s-triazine molecules included 
in our moiety which are described as under.  
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SECTION : I   SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(6"-ARYL)-2"-AMINO-3"-CYANOPYRIDINE-4"-
YL]-PHENYLAMINO}-6-[BIS-(2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE  
 
SECTION : II  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(4"-ARYL)-3"-CYANO-2"-METHOXY-PYRIDINE-
6"-YL]-PHENYL AMINO}-6-[BIS(2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
SECTION : III  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(4"-ARYL)-3"-CYANO-2"-ETHOXY PYRIDINE -6"-
YL]-PHENYL AMiNO}-6-[BIS-(2"'-CHLOROETHYL) 
AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE.  
 
SECTION : IV  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(4"-ARYL)-3"-CYANO-2"-HYDROXY PYRIDINE-
6"-YL]-PHENYL AMINO}-6-[BIS-(2"'-CHLOROETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE 
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SECTION : I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL-2"-
AMINO-3"-CYANOPYRIDINE-4"-YL]-PHENYLAMINO}-6-[BIS-(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE  
 
 Pyridine nucleus plays in important role in medicine agriculture and industrial 
chemistry. To further assess the potential of such a classes of compounds, cyano 
pyridine derivative of 2-{4'-[(6"-Aryl-2"-amino-3"-cyano pyridine-4"-yl] phenyl 
amino}-6-[Bis(2"-chloroehtyl) amino]-4-methoxy-1,3,5-triazine of Type(IX) have 
been synthesised by the condensation of 2-{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl 
amino}-6-[Bis (2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine, chalcones of 
Type(I) with malononitirle in presence of ammonium acetate.  
R
NCl
N
N
NCl
O
N
H
N
NH
2
NC
(Type-IX) R = Aryl  
 The constitution of the products have been characterised by elemental analyses 
IR, 
1
H NMR,  Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 μg.  
 
 The details have been cited in the part : I, section : I, Page no. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[6"-(4""-METHOXYPHENYL)-2"-AMINO-
3"-CYANOPYRIDINE-4"-YL]-PHENYLAMINO}-6-[BIS-(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE  
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophotometer, frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyridine Nitrile 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
N-H Str. (-NH2) 
C=N  Str. 
C-N  Str. 
2890 
2873 
1440 
1375 
3041 
1274 
842 
1517 
1170 
1623 
3460 
1604 
1274 
1076 
771 
3350 
1604 
1087 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
3350-3250 
1612-1550 
1220-1020 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[6"-(4""-METHOXYPHENYL)-2"-
AMINO-3"-CYANOPYRIDINE-4"-YL]-PHENYLAMINO}-6-[BIS-(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE  
 
Internal standard : TMS; solvent : DMSO :  Instrument : DPX-200 spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
3.66-3.86 
7.66-7.86 
8.10-8.53 
4.79-4.81 
2.50-2.89 
9.45 
9.87-9.96 
7.01-7.03 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
1 H 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-NH2 g 
-Ar h 
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MASS SPECTRAL STUDY OF 2-{4'-[6"-(4""-METHOXYPHENYL)-2"-AMINO-3"-CYANOPYRIDINE-4"-YL]-PHENYLAMINO}-
6-[BIS-(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 565)  
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4 (21) 3-OH C6H4 (18) 4-OH C6H4 (21) 3-OH C6H4 (20) C6H5 (20) 
 4-Br. C6H4 (22) 4-OH C6H4 (20) 4-Br. C6H4 (20) 4-OH C6H4 (22) 4-OH C6H4 (23) 
 4-NO2 C6H4 (21) 4-Br. C6H4 (18) 4-NO2 C6H4 (22) 4-NO2 C6H4 (21) 3-NO2 C6H4 (21) 
  3-NO2 C6H4 (19)  4-N,N(CH3)2 4-NO2 C6H4 (22) 
    C6H4 (20)  
   Comparable activity with known standard drugs  
Ampicilin           50 µg 23 18 17 27 - 
Chloramphenicol   " 24 19 25 26 - 
Norfloxacin           " 24 19 25 26 - 
Greseofulvin           " - - - - 23 
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REACTION SCHEME 
 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H
N
NH
2
NC
(Type-IX) R = Aryl
CH2(CN)2
CH3COONH4
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(6"-ARYL)-2"-AMINO-3"-CYANOPYRIDINE-4"-YL]-
PHENYLAMINO}-6-[BIS-(2"'-CHLOROETHYL) AMINO]-4-METHOXY-
1,3,5-TRIAZINE 
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine  
 For synthesis, Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-
triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis (2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(D)  Synthesis of 2-{4'-[3"(4""-Methoxy phenyl)-2"-propene-1"-one]- phenyl 
amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis Part-1, Section-I, Page No. 36-38. 
 
(E) Synthesis of 2-{4'-[(6”-(4""-Methoxy phenyl)-2"-amino - 3"-cyano 
pyridine-4"-yl]-phenyl amino}-6-[Bis (2"-chloroethyl) amino]-4-methoxy-
1,3,5-triazine.  
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 A mixture of 2-{4'-[3"(4""-methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine (5.02 gm, 
0.01 M); malononitrile (0.66 g, 0.01M) and ammonium acetate (0.77 gm, 0.01 
M) and dioxane (25 ml.) The reaction mixture was refluxed 10 hrs. at 120º C., 
The reaction mixture was poured into crushed ice, filtered, dried, crystallised 
from dioxane, yield : 70%. M.P. : 228º C. (Found : C : 57.31; H : 4.59; N : 
19.81; C27H26O2N8Cl2 required C : 57.34; H : 4.60; N : 19.82%)  
  Simillarly other compounds were synthesised and their physical data 
are recorded in Table No. 17. 
 
(F) Antimicrobial activity of 2-{4'-(6"-Aryl) - 2"-amino-3"-cyano pyridine-
4"-yl]-Phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4- methoxy-1,3,5-
triazine.  
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page No. 39-41.  
 The zone of inhibition of the test solutions are recorded in Table No. 18.  
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TABLE NO : 17 : PHYSICAL CONSTANTS OF 2-{4'-[(6"-ARYL)-2"-AMINO-3"-CYANOPYRIDINE-4"-YL]-PHENYLAMINO}-6-
[BIS-(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C26H24Cl2N8O 199 76 20.93 20.91 
2. 2-OH C6H4 C26H29Cl2N8O2 215 69 18.24 18.21 
3. 3-OH C6H4 C26H24Cl2N8O2 139 72 18.24 18.20 
4. 4-OH C6H4 C26H24Cl2N8O2 206 82 18.24 18.19 
5. 4-OCH3 C6H4 C27H26Cl2N8O2 228 70 19.82 19.81 
6. 4-OH, 3-OCH3 C6H3 C27H26Cl2N8O3 236 73 19.27 19.23 
7. 4-Br. C6H4 C26H23Br Cl2N8O 219 67 18.24 18.22 
8. 3-NO2 C6H4 C26H23Cl2N9O3 207 71 21.72 21.70 
9. 4-NO2 C6H4 C26H23Cl2N9O3 206 79 21.72 21.72 
10 4-N,N(CH3)2 C6H4 C28H29Cl2N9O 225 85 21.79 21.75 
11. C4H3O (Fufuryl) C24H22Cl2N8O2 186 87 21.33 21.28 
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TABLE NO : 18 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(6"-ARYL)-2"-AMINO-3"-CYANOPYRIDINE-4"-YL]-
PHENYLAMINO}-6-[BIS-(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 15 14 16 18 20 
2 2-OH C6H4 14 16 15 19 18 
3 3-OH C6H4 17 18 19 20 19 
4 4-OH C6H4 21 20 21 22 23 
5 4-OCH3 C6H4 19 17 16 17 19 
6 4-OH, 3-OCH3 C6H3 18 15 15 16 18 
7 4-Br. C6H4 22 18 20 15 13 
8 3-NO2 C6H4 20 19 18 18 21 
9 4-NO2 C6H4 21 17 22 21 22 
10 4-N,N(CH3)2 C6H4 18 15 17 20 16 
11 C4H3O (Fufuryl) 16 14 19 16 15 
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SECTION - II 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3"-
CYANO-2"-METHOXY-PYRIDINE-6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
 In recent years, much interest have been foucused of cyanopyridine 
derivatives showed wide range of application in the field of pharmaceutical. In view 
of getting 2-{4'-[(4"-Aryl)-3"-cyano-2"-methoxy-pyridine-6"yl]phenylamino}-6-
[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine of Type(X) have been 
synthesised by the condensation of 2-{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl 
amino}-6-[Bis (2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine with malono nitrile 
in the presence of sodium methoxide.  
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-X) R = Aryl  
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR, Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the part : I, Section : I, Page no. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[4"-(4""-METHOXYPHENYL)-3"-CYANO-
2"-METHOXY)-PYRIDINE-6"-YL]-PHENYLAMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed Reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyridine Nitrile 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=N  Str. 
C-N  Str. 
2910 
2876 
1458 
1363 
3024 
1298 
837 
1458 
1215 
1593 
3413 
1635 
1244 
1045 
792 
2216 
1581 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
2240-2120 
1650-1520 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[4"-(4""-METHOXYPHENYL)-3"-
CYANO-2"-METHOXY)-PYRIDINE-6"-YL]-PHENYLAMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Internal standard : TMS;  solvent : CDCl3 ;  Instrument : BRUKER spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
 
3.76-3.96 
7.41-7.84 
7.93-8.24 
4.00-4.96 
2.63-3.23 
10.09 
7.97 
 
9 H 
4 H 
4 H 
4 H 
4 H 
1 H 
1 H 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-NH2 g 
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MASS SPECTRAL STUDY OF 2-{4'-[4"-(4""-METHOXYPHENYL)-3"-CYANO-2"-METHOXY)-PYRIDINE-6"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 580) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH, 3-OCH3  4-OH C6H4(17) 4-Br. C6H4(21) 3-OH C6H4(20) 3-OH C6H4(23) 
 C6H3 (20) 4-Br. C6H4(19) 4-NO2 C6H4(20) 4-OH C6H4(21) 4-OH C6H4(21) 
 4-NO2 C6H4(19) 4-NO2 C6H4(20)  4-Br. C6H4(22) 4-NO2 C6H4(20) 
 C4H3O (19)   4-NO2 C6H4(20)  
      
   Comparable activity with known standard drugs  
Ampicilin           50 µg 23 18 17 27 - 
Chloramphenicol    “ 24 19 25 26 - 
Norfloxacin           “ 24 19 25 26 - 
Greseofulvin            “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-X) R = Aryl
CH2(CN)2
CH3ONa
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3"-
CYANO-2"-METHOXY)-PYRIDINE-6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetylphenyl amino)-4, 6-dichloro-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetylphenyl amino) -6-chloro-4-methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis- (2"-chloroethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page No. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxyphenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[4"-(4""-Methoxyphenyl)-3"-cyano-2"-methoxy-
pyridine-6"-yl]-phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4- 
methoxy-1,3,5-triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxyphenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis(2'"-chloro ethyl)-amino]-4-methoxy-1,3,5,- triazine (5.02 gm, 
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0.01M) methanol (25 ml) malono nitrile (0.66 gm, 0.01 M); sodium 
methoxide, (0.44 g., 0.01M) The reaction mixture was refluxed 10 hrs. at 170º 
C. in dioxane. The product was poured into crushed ice, filtered and dried, 
crystallised from dioxane, yield : 78%, M.P. : 188º C. (Found : C : 5780; H : 
4.69; N : 16.81; C28H27O3N7Cl2 required C : 57.83; H : 4.71 ; N : 16.89%) 
   Simillarly other compounds were synthesised and their physical data 
are recorded in Table no. 19.  
 
(F) Antimicrobial activity of 2-{4'[(4"-Aryl-3"-cyano-2", methoxy)-pyridine-
6"-yl]-phenyl amino}-6-[Bis. (2"'-chloro ethyl) amino]-4- methoxy-1,3,5-
triazine.  
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page no. 39-41.  
 The Zone of inhibition of the test solution are recorded in Table no. 20. 
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TABLE NO : 19 : PHYSICAL CONSTANTS OF 2-{4'-[(4"-ARYL)-3"-CYANO-2"-METHOXY-PYRIDINE-6"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C27H25Cl2N7O2 201 64 17.81 17.80 
2. 2-OH C6H4 C27H25Cl2N7O3 212 68 17.31 17.30 
3. 3-OH C6H4 C27H25Cl2N7O3 179 72 17.31 17.29 
4. 4-OH C6H4 C27H25Cl2N7O3 153 75 17.31 17.27 
5. 4-OCH3 C6H4 C28H27Cl2N7O3 188 78 16.89 16.81 
6. 4-OH, 3-OCH3 C6H3 C28H27Cl2N7O4 176 80 16.44 16.42 
7. 4-Br. C6H4 C27H24BrCl2N7O2 205 85 15.58 15.53 
8. 3-NO2 C6H4 C27H24Cl2N8O4 164 79 18.82 18.81 
9. 4-NO2 C6H4 C27H24Cl2N8O4 179 78 18.82 18.80 
10 4-N,N(CH3)2 C6H4 C29H30Cl2N8O2 171 81 18.88 18.83 
11. C4H3O (Furfuryl) C25H23Cl2N7O3 119 85 18.14 18.09 
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TABLE NO : 20 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3"-CYANO-2"-METHOXY-PYRIDINE-6"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in 
mm. 
  B. mega B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 13 12 14 16 17 
2 2-OH C6H4 14 13 16 19 19 
3 3-OH C6H4 17 14 18 20 23 
4 4-OH C6H4 18 17 18 21 21 
5 4-OCH3 C6H4 15 13 16 17 18 
6 4-OH, 3-OCH3 C6H3 20 14 14 15 15 
7 4-Br. C6H4 16 19 21 22 16 
8 3-NO2 C6H4 17 18 18 18 17 
9 4-NO2 C6H4 19 20 20 20 20 
10 4-N,N(CH3)2 C6H4 15 18 16 17 14 
11 C4H3O (Furfuryl) 19 17 17 19 18 
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SECTION : III 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3"-
CYANO-2"-ETHOXY PYRIDINE -6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE.  
 
 Pyridine derivatives have been reported to have various pharmacological 
activities like antibacterial, antiviral, antifungal etc. With a view of getting better 
therapeutic activity 2-{4'-[(4"-aryl)-3"-cyano-2"-ethoxy-pyridine-6"-yl]-phenyl 
amino}-6-[Bis (2"-chloroethyl) amino]-4-methoxy-1,3,5-triazine of Type-(XI) have 
been synthesised by the condensation of 2-{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl 
amino}-6-[Bis (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine chalcones of 
Type(I) with malononitrile in the presence of sodium ethoxide.  
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-XI) R = Aryl  
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR, Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the Part P I, Section : I, Page No. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[4"- (4""-METHOXYPHENYL)-3"-CYANO-
2"-ETHOXY PYRIDINE -6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE.  
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyridine Nitrile 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=N  Str. 
C-N  Str. 
2947 
2875 
1458 
1363 
3024 
1149 
837 
1458 
1215 
1593 
3411 
1577 
1215 
1047 
792 
2216 
1577 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
2240-2120 
1650-1520 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[4"- (4""-METHOXYPHENYL)-3"-
CYANO-2"-ETHOXY PYRIDINE -6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLOROETHYL) AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE.  
 
Internal standard : TMS; solvent : CDCl3 ;  Instrument : BRUKER spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
 
3.77-3.90 
7.15-7.17 
7.67-7.89 
4.03-4.05 
2.33-2.54 
9.85 
3.30 
2.33 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
3 H 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Quartate 
Triplet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-OCH2 g 
-CH2-CH3 h 
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MASS SPECTRAL STUDY OF 2-{4'-[4"- (4""-METHOXYPHENYL)-3"-CYANO-2"-ETHOXY PYRIDINE -6"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE. (M.W. : 594) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 3-OH C6H4 (22) 2-OH C6H4 (17) 3-OH C6H4 (21) 3-OH C6H4 (23) C6H5 (20) 
  3-OH C6H4 (19) 4-OH C6H4 (22) 4-OH C6H4 (24) 4-OH C6H4 (21) 
  4-OH C6H4 (20) 3-NO2 C6H4 (21) 3-NO2 C6H4 (23) 4-NO2 C6H4 (23) 
  4-Br C6H4 (18) 4-NO2 C6H4 (23) 4-NO2 C6H4 (22)  
  4-NO2 C6H4 (19)    
   Comparable activity with known standard drugs  
Ampicilin           50 µg 23 18 17 27 - 
Chloramphenicol  “ 24 19 25 26 - 
Norfloxacin         “ 24 19 25 26 - 
Greseofulvin          “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H N
O
CN
(Type-XI) R = Aryl
CH2(CN)2
C2H5ONa
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'[(4"-ARYL)-3"-CYANO-2"-ETHOXY PYRIDINE -6"-
YL]-PHENYL AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY 
- 1, 3, 5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino) 4, 6-dichloro-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38.  
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-
triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'- Acetyl Phenyl amino)-6-[Bis(2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxyphenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis. (2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[4"-(4""-Methoxy phenyl)-3"-cyano-2"-ethoxy-
pyridine-6"-yl]-phenyl amino}-6- [Bis (2"'-chloro ethyl) amino]-4-
methoxy-1,3,5-triaine.  
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 A mixture of 2-{4'[3"-(4""-methoxyphenyl)-2"-Propene-1"-one] phenyl 
amino}-6-[Bis.(2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine (5.02 gm, 
0.01M) and malnonitrile (0.66 gm, 0.01M); sodium ethoxide (0.68 gm, 
0.01M) and ethanol (15 ml) : The reaction mixture was refuxed for 12 hrs. at 
100º C temp. The reaction mixture was poured into crushed ice, filtered, dried 
and crystallised from ethanol. Yield : 65%, M.P.: 248º C. (Found : C : 58.55;  
H; 4.85; N : 16.48; C29H29O3N7Cl2 required C : 58.58; H : 4.88; N : 16.49%).  
  Simillarly other compounds were synthesised and their physical data 
recorded in Table no. 21. 
 
(F) Antimicrobial activity of 2-{4'-[4" -(Aryl)-3"-cyano-2"-ethoxypyridine-
6"-yl]-phenyl amino}-6-[Bis. (2"'- chloro ethyl) amino]-4- methoxy-1, 3, 5-
triazine.  
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page No. 39-41.  
 The zone of inhibition of the test solution are recorded in Table no. 22. 
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TABLE NO : 21 : PHYSICAL CONSTANTS OF 2-{4'-[(4"-ARYL)-3"-CYANO-2"-ETHOXY PYRIDINE -6"-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLOROETHYL) AMINO]-4-METHOXY - 1, 3, 5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C28H27Cl2N7O2 215 27 17.37 17.31 
2. 2-OH C6H4 C28H27Cl2N7O3 193 52 16.89 16.82 
3. 3-OH C6H4 C28H27Cl2N7O3 252 60 16.89 16.85 
4. 4-OH C6H4 C28H27Cl2N7O3 279 62 16.89 16.88 
5. 4-OCH3 C6H4 C29H29Cl2N7O2 248 65 16.49 16.48 
6. 4-OH, 3-OCH3 C6H3 C29H29Cl2N7O4 195 58 16.06 16.05 
7. 4-Br. C6H4 C29H26BrCl2N7O2 180 70 15.24 15.21 
8. 3-NO2 C6H4 C28H26Cl2N8O4 279 73 18.39 18.38 
9. 4-NO2 C6H4 C28H26Cl2N8O4 183 75 18.39 18.32 
10 4-N,N(CH3)2 C6H4 C30H32Cl2N8O2 218 57 18.44 18.41 
11. C4H3O (Furfuryl) C26H25Cl2N7O3 187 58 17.68 17.66 
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TABLE NO : 22 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3”-CYANO-2"-ETHOXY-PYRIDINE-6”-YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in 
mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 18 17 17 20 20 
2 2-OH C6H4 13 17 20 21 16 
3 3-OH C6H4 22 19 21 23 18 
4 4-OH C6H4 19 20 22 24 21 
5 4-OCH3 C6H4 19 15 17 18 17 
6 4-OH, 3-OCH3 C6H3 15 16 18 17 19 
7 4-Br. C6H4 14 18 19 19 18 
8 3-NO2 C6H4 16 17 21 23 20 
9 4-NO2 C6H4 18 19 23 22 23 
10 4-N,N(CH3)2 C6H4 16 12 18 16 17 
11 C4H3O (Furfuryl) 14 13 18 19 18 
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SECTION : IV 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4"-ARYL)-3"-
CYANO-2", HYDROXY-PYRIMIDINE-6"-YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 Pyridine derivatives have been found to possess wide range of therapeutic 
activities and industrial importance with a view of getting 2-{4'-[(4"-aryl)- 3"-cyano-
2"-hydroxy pyridine-6"-yl] phenyl amino}-6-[Bis (2"'-chloroethyl) amino] -4-
methoxy-1,3,5-triazine of Type-(XII) have been synthesised by the condensation of 2-
{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl amino}-6- [ Bis (2"'- chloroethyl) amino]-4-
methoxy-1,3,5-triazine with ethyl cyano acetate in the presence of ammonium acetate.  
R
NCl
N
N
NCl
O
N
H N
OH
CN
(Type-XII) R = Aryl  
 The constitution of the synthesised products have been characterised by 
elemental analysis IR, 
1
H NMR,  Mass spectral study. The products were screened for 
their antimicrobial activity at a concentration of 50 µg  
 
 The details have been cited in the part : I, Section : I, Page no. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[4"-(4""METHOXY PHENYL)-3”-CYANO-
2”-HYDROXY-PYRIDINE-6”YL] PHENYL AMINO}-6-[BIS(2"'-CHLORO 
ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyridine Nitrile 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=N  Str. 
C-N  Str. 
2903 
2873 
1452 
1363 
3090 
1215 
823 
1452 
1081 
1593 
3311 
1635 
1245 
1047 
792 
2240 
1577 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
2240-2120 
1650-1520 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[4"-(4""-METHOXY PHENYL)-3”-
CYANO-2”-HYDROXY-PYRIDINE-6”YL]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Internal standard : TMS; solvent : DMSO ; Instrument : BRUKER spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
 
3.82-3.92 
7.20-7.90 
7.99-8.32 
4.99-5.02 
2.69-3.29 
10.15 
9.64 
7.99-8.03 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
1 H 
1 H 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-OH g 
Ar-OH i 
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MASS SPECTRAL STUDY OF 2-{4'-[4"-(4""-METHOXY PHENYL-3”-CYANO-2”-HYDROXY-PYRIDINE-6”YL]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 566) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity  
Zone of inhibition in m.m.  
 B. mega.  
R 
B. subtillis  
R 
E. coli.  
R 
P. fluorescens.  
R 
A. awamori. 
R 
 4-OH C6H4 (20) 4-OH C6H4 (19) 3-OH C6H4 (19) 4-OH C6H4 (23) C6H5 (20) 
 4-Br. C6H4 (23) 3-NO2 C6H4 (20) 4-OH C6H4 (22) 4-Br. C6H4 (23) 4-OH C6H4 (21) 
  4-NO2 C6H4 (21) 4-OH, 3-OCH3  4-Br C6H4 (23) 
   C6H4 (19)  4-NO2 C6H4 (22) 
   4-NO2 C6H4 (21)   
 
Comparable activity with known standard drugs 
 
Ampicilin            50 µg. 23 18 17 27 - 
Chloramphenicol     “  24 19 25 26 - 
Norfloxacin             “ 24 19 25 26 - 
Greseofulvin              “ - - - - 23 
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RECATION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H N
OH
CN
(Type-XII) R = Aryl
CH3COONH4
Ethyl Cyano Acetate
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
SYNTHESIS OF 2-{4'-[(4"-ARYL)-3"-CYANO-2"-HYDROXY-PYRIDIN-6"-
YL]PHENYL AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-
METHOXY-1,3,5-TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5- 
triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl Phenyl amino)-6-[Bis (2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis (2"'-chloro ethylamino]-4- methoxy-1,3,5-triazine  
 For synthesis, see Part-I, Section I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[4"-(4""-Methoxy phenyl)-3"-cyano-2"-hydroxy) 
pyridine-6"-yl]-phenyl amino}-6-[Bis (2"'-chloroethyl) amino]-4-methoxy-
1,3,5-triazine  
 A mixture of 2-{4'-[3"-(4""-methoxyphenyl) -2"-propene-1"-one]phenyl 
amino}-6-[Bis. (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine (5.02 gm, 
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0.01 M); ethyl cyano acetate (1.13 ml; 0.01M) and methanol (10 ml). The 
reaction mixtrue was refluxed for 10 hrs. at 100º C in presence of ammonium 
acetate. The reaction mixture was poured into crushed ice, filtered, dried and 
crystallised from dioxame, Yield : 65%, M.P. : 191º C. (Found : C : 57.21; H : 
4.39; N : 17.30; C27H25O3N7Cl2,  required C : 57.24; H : 4.41; N : 17.31%)  
   Simillarly other compounds were synthesised and their physical data 
are recorded in Table no. 23. 
 
(F) Antimicrobial activity of 2-{4'-[(4"-Aryl)-3”-cyano -2"-hydroxypyridine-
6"-yl]-phenyl amino}-6- [Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-
triazine.  
  
 The antimicrboial testing was carried out as described in Part-I, Section-I, 
Page NO. 39-41.  
 The zone of inhibition of the test solution are recorded in Table no. 24. 
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TABLE No  : 23 : PHYSICAL CONSTANTS OF 2-{4'-[(4"-ARYL)-3”-CYANO -2"-HYDROXYPYRIDINE-6"-YL] -PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C26H23Cl2N7O2 235 63 18.28 18.28 
2. 2-OH C6H4 C26H23Cl2N7O3 230 51 17.75 17.70 
3. 3-OH C6H4 C26H23Cl2N7O3 228 57 17.75 17.71 
4. 4-OH C6H4 C26H23Cl2N7O3 238 65 17.75 17.72 
5. 4-OCH3 C6H4 C27H25Cl2N7O3 191 65 17.31 17.30 
6. 4-OH, 3-OCH3 C6H3 C27H25Cl2N7O4 232 68 16.83 16.82 
7. 4-Br. C6H4 C26H22BrCl2N7O2 192 63 15.93 15.91 
8. 3-NO2 C6H4 C26H22Cl2N8O4 202 71 19.27 19.26 
9. 4-NO2 C6H4 C26H22Cl2N8O4 118 53 19.27 19.25 
10 4-N,N(CH3)2 C6H4 C28H28Cl2N8O2 143 59 19.34 19.31 
11. C4H3O (Furfuryl) C24H21Cl2N7O3 235 64 18.83 18.82 
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TABLE NO : 24 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(4''-ARYL)-3''-CYANO-2''''-HYDROXY PYRIDIN-6''YL]- AMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 13 16 14 16 20 
2 2-OH C6H4 17 17 15 19 18 
3 3-OH C6H4 19 16 19 18 17 
4 4-OH C6H4 20 19 22 23 21 
5 4-OCH3 C6H4 18 15 18 20 19 
6 4-OH, 3-OCH3 C6H3 17 14 19 21 16 
7 4-Br. C6H4 23 16 15 23 23 
8 3-NO2 C6H4 17 20 17 20 19 
9 4-NO2 C6H4 19 21 21 19 22 
10 4-N,N(CH3)2 C6H4 14 14 15 16 18 
11 C4H3O (Furfuryl) 17 12 18 15 19 
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PART - VI 
STUDIES ON CYANOPYRANS 
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STUDIES ON CYANOPYRANS 
INTRODUCTION  
 Pyran derivatives are associated with wide range of applications in various 
fields like pharmaceutical, dyes, insecticides and sweet smelling substance. Pyran ring 
system also occurs in nature abundantly such as in large number of natural coloured 
compounds, in Vitamin E, incloves, in poisons, in certain alkaloids and other 
substances.  
 
 Pyran are six member doubly unsaturated compounds containing one oxygen 
atom in the ring. The double bonds may be conjugated known as -or 1, 2-pyran or it 
may be isolated known as -or 1, 4-pyran.  
O O
1,2-dihydropyran 1,4-dihydropyran  
SYNTHETIC ASPECT  
 Various methods for the preparation of pyran derivatives have been cited in 
the literature
264-273
 
 
1. Reaction between , -unsaturated carbonyl system with malononitrile led to 
correspnding 2-amino-3-cyano-4H-pyran
274
 
 
2. A. Z. Elssar et al.
275
 prepared 3-cyano-pyran derivatives by the reaction of -
cyano chalcone derivative with C2H5COCH2COOCH3 in basic medium.  
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O
R'
R
O
O
NC
R
O
R'
CN
O O
O
HO-
+
 
3. H. Abdel - Ghyan et. al.
276
 have been synthesized cyano derivatives by the 
reaction of 2-coumariylidene malononitrile with active methylene containing 
compounds.  
O
CN
CN
R
R'
O
R
O
O
R
O
NH
2
R'
R
O
CN
+
 
4. -Siloxy acrylonitrile were reacted with chalcones to furnish the respective 
cyano-4H-pyran derivatives
277
 
5. M. G. Assay et al.
278
 have synthesized some cyanopyran derivatives by the 
reaction of cyclohexane with cinnamon nitriles.  
O
R
NH
2
CN
 
6. R. De Lera Angel and co-workers
279
 synthesized pyran derivatives by thermal 
electrolytic ring closure of divinylallenals.  
7. In recent, A. M. Hussein and et al.
280
 prepared some novel derivatives of 
cyanopyran.  
X
O
O
CN
Ar
O Ar
NH
2
CN
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REACTION MECHANISM  
 The reaction mechanism for the formation of pyran derivatives proceeds 
through Micheal addition of active methylene group of malononitrile to the -carbon 
atom of chalcone described as under.  
 
THERAPEUTIC IMPORTANCE  
 Polysubstituted pyran derivatives are biologically interesting class of 
compounds
281-282
 They are associated with various pharmaceutical properties like. 
1. Anticancer
283
 
2. Antiinvasive
284
 
3. Anti-HIV
285,286
 
4. Antiallergic
287
 
5. Antifungal
288,289
 
6. Cytotoxic
290
 
7. Antitumor
291
 
8. Antiviral
292
 
9. Antipyratic
293
 
10. Analgesic
294
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 M. A.  AI-Haiza and co-workers
295
 prepared some cyanopyran derivatives (I) 
and tested their antibacterial and antifungal activities. A. V. Samet
296
 et al.  
synthesized 2-amino-5-azolyl-3-cyano-4H-pyrans (II) and evaluated for biological 
activity. A. Z. Elassar et al.
297
 reported that cyanopyran exhibited in vitro antifungal 
and antibacterial activities.  
O
O
NH
2
R
Ar
O O
N N
N
N
R
NH
2
CN
NH
2
(I)                                                (II)  
 Moreover, R. M. Shaker.
298
 have prepared some coumarin ring containing 2-
amino-3-cyanopyran (III) derivatives and studied their antimicrobial activity. Y. D. 
Kulkarni and co-workers
299
 synthesized some pyran derivatives as CNS active agents. 
A. A. Hassainien et al.
300
 prepared 2-amino-3-cyano-7, 7-dimethyl-4-substituted 
phenyl-5-oxo-4,5,6,8-tetrahydropyran and tested for their biological activities.  
OO
NH
2 NH2
O O
O O
CN NC
(III)
 
Further more, A. Krauze et al.
301
 synthesized 5-(4-pyridyl) derivatives of 2-
amino-4H-pyran (IV) for antimicrobial activity. S. Fowzia, Al-Saleh
302
 and coworkers 
synthesized some new cyanopyran derivatives and reported as antimicrobial agents. 
Some pyran derivatives have been pantented for their use as gastric acid secretion 
inhibitors
303
 inhibitors of cell proliferation
304
 antihypertensive
305
 antitumor
306
 
antagonists
307-308
 and antiviral agents
309
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O
N
CN
(IV)  
 H. S. Joshi et al.
310
 and co-workers recently have synthesized some new cyano 
pyran (V) derivatives as anticancer and antimicrobial agents.  
O
NH
2
R
CN
Br
(V)  
 Thus with an effort to capitalize the biological potential of the heterocyclic 
system and to synthesize interesting compounds having better biological potential, the 
titled compounds have been investigated which have been described as under.  
 
SECTION : I  : SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
[(2"- AMINO-4"-ARYL-4"-(H)-PYRAN-3-(CARBONITRILE)-
6"-YL]-PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
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SECTION : I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(2"- AMINO-4"-
ARYL-4"-(H)-PYRAN-3-(CARBONITRILE)-6"-YL]-PHENYLAMINO}-6-[BIS 
(2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
 Cyanopyran derivatives have been reported to have various pharmalogical 
activities like antibacterial, antiviral, antifungal etc. In order to develop better 
medicinally important componds. It was considered of interest to synthesised some 
cyanopyran derivatives shown as under. Cyanopyran derivatives of 2-{4'[(2"-amino-
4"-(H)-pyran-3-carbonitrile)-6"-yl]-phenyl amino}-6-[Bis(2"'-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine of Type (XIII) have been synthesised by the reaction of 
chalcones of Type (I) with malononitrile in pyridine.  
R
NCl
N
N
NCl
O
N
H
NH
2
CN
O
(Type-XIII) R = Aryl  
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR,  Mass spectral study. The products were screened for antimicrobial 
activity at concentration of 50 µg.  
 
 The details have been cited in the Part : I, Section I, Page No. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[2"- AMINO-4"-(4""-METHOXYPHENYL) -
4"-(H)-PYRAN-3-(CARBONITRILE-6"-YL]-PHENYLAMINO}-6-[BIS(2"'-
CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophotometer frequency; range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Pyran Nitrile 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
N=N  Str. 
C=N  Str. 
C-N  Str. 
2948 
2889 
1458 
1355 
3055 
1164 
823 
1458 
1068 
1593 
3405 
1649 
1245 
1068 
769 
3272 
2190 
1589 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
3350-3250 
2240-2120 
1650-1520 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[(2"- AMINO- 4" - (4"" -
METHOXYPHENYL) - 4" - (H) – PYRAN – 3 - ( CARBONITRILE - 6" – YL ] 
-PHENYLAMINO}-6-[BIS-(2"'-CHLOROETHYL)-AMINO]-4-METHOXY-
1,3,5-TRIAZINE. 
 
Internal standard : TMS; solvent : DMSO ;  Instrument : BRUKER spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
 
3.33-3.37 
7.17-7.63 
8.04-8.96 
4.30-4.35 
2.40-2.87 
8.96 
9.38-9.47 
6.52-6.54 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
1 H 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-NH2 g 
Ar-H i 
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MASS SPETRAL STUDY OF 2-{4'-[2"- AMINO- 4" - (4"" -METHOXYPHENYL) - 4" - (H) – PYRAN – 3 - (CARBONITRILE -6"-
YL]-PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 568) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 C6H5 (21) 4-OH C6H4(18) 3-OH C6H4(20) 3-OH C6H4(23) 4-OH C6H4(21) 
 4-OH C6H4(20) 3-NO2 C6H4(18) 4-OH C6H4(21) 4-OH C6H4(24) 4-Br C6H4(22) 
 4-NO2 C6H4(21) 4-NO2 C6H4(20) 4-NO2 C6H4(22) 4-Br C6H4(22)  
    C4H3O(23)  
 
Comparable activity with known standard drugs 
 
Ampicilin            50 µg 23 18 17 27 - 
Chloramphenicol     “ 24 19 25 26 - 
Norfloxacin             “ 24 19 25 26 - 
Greseofulvin              “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
NCl
N
N
NCl
O
N
H
NH
2
CN
O
(Type-XIII) R = Aryl
CH2(CN)2
Pyridine
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(2"- AMINO-4"-ARYL-4"-(H)-PYRAN-3-CARBO 
NITRILE)-6"-YL]-PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-traizine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38.  
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-trazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino-6-[Bis(2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38.  
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-1, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[2"-Amino-4"-(4""-methoxy phenyl)-4"-(H)-pyran-3-
carbonitrile-6"-yl]-phenyl amino}-6-[Bis - (2"'-chloro ethyl) amino]-4-
methoxy-1,3,5 - triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)-2"- propene-1"-one] phenyl 
amino}-6-[Bis- (2"'-chloroethyl) amino]-4-methoxy-1,3,5- triazine (5.02 gm, 
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0.01M) and malonontirile (0.66 gm, 0.01 M) in Pyridine (10 ml). The reaction 
mixture was reluxed for 12 hrs. at 120º C. The reaction mixture was poured 
into crushed ice, filtered, dried and crystallised from dixoane, yield : 67%,           
M. P. : 101º C. (Found : C : 57.01; H : 4.72; N : 17.21; C27H27O3N7Cl2 
required C : 57.04; H : 4.75; N : 17.25%) 
  Simillarly other compounds were synthesised and their physical data 
are recorded in Table no. 25.  
 
(F) Antimicrobial activity of 2-{4'-[(2"-Amino-4"-aryl-4"-(H)-pyran-3-carbo 
nitrile)-6"-yl]-phenyl amino}-6-[Bis (2"'-chloro ethyl) amino]-4-methoxy-
1,3,5-triazine.  
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page No. 39-41. 
 
 The zone of inhibition of the test solution are recorded in Table no. 26. 
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TABLE NO : 25 : PHYSICAL CONSTANTS OF 2-{4'-[(2"- AMINO-4"-ARYL-4"-(H)-PYRAN-3-CARBONITRILE)-6"-YL]-
PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C26H25Cl2N7O2 157 58 18.21 18.20 
2. 2-OH C6H4 C26H25Cl2N7O3 198 62 17.68 17.66 
3. 3-OH C6H4 C26H25Cl2N7O3 205 65 17.68 17.67 
4. 4-OH C6H4 C26H25Cl2N7O3 192 70 17.68 17.52 
5. 4-OCH3 C6H4 C27H27Cl2N7O3 101 97 17.25 17.21 
6. 4-OH, 3-OCH3 C6H3 C27H27Cl2N7O4 117 68 16.78 16.75 
7. 4-Br. C6H4 C26H24BrCl2N7O2 205 81 15.88 15.83 
8. 3-NO2 C6H4 C26H24Cl2N8O4 215 83 19.21 19.19 
9. 4-NO2 C6H4 C26H24Cl2N8O4 229 79 19.21 19.18 
10 4-N,N(CH3)2 C6H4 C28H30Cl2N8O2 112 73 19.27 19.23 
11. C4H3O (Furfuryl) C24H23Cl2N7O3 145 83 18.56 18.53 
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TABLE NO : 26 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(2"- AMINO-4"-ARYL-4"-(H)-PYRAN-3-CARBONITRILE)-6"-YL]-
PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 21 14 17 20 17 
2 2-OH C6H4 18 13 15 21 18 
3 3-OH C6H4 19 16 20 23 19 
4 4-OH C6H4 20 18 21 24 21 
5 4-OCH3 C6H4 11 14 19 18 18 
6 4-OH, 3-OCH3 C6H3 17 16 17 17 17 
7 4-Br. C6H4 15 15 18 22 22 
8 3-NO2 C6H4 16 18 19 17 15 
9 4-NO2 C6H4 21 20 22 19 16 
10 4-N,N(CH3)2 C6H4 15 12 18 18 16 
11 C4H3O (Furfuryl) 12 13 17 23 18 
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PART - VII 
STUDIES ON QUINOXALINES 
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STUDIES ON QUINOXALINES 
 
INTRODUCTION  
 The quinoxaline or benzopyrazine (I) are the product formed by spontaneous 
condensation of o-phenylene diamine with 1, 2-dicarbonyl compounds.  
N
(I)  
 This reaction was discovered by Korner
311
 and by Hinsberg
312
 independently. 
Since quinoxalino are also obtained when -dihalo ketones condensed with  
o-phenyliene diamine. The structure of these cyclic base are obvious from the mode 
of formatiora and analytical data. The ring structure was further confirmed by Gabriel. 
who demonstrated experimentally the relationship between the quinoxaline and the 
pyrazines by oxidizing quinoxaline to pyrazine-2, 3-dicarboxylic acid.  
 
SYNTHETIC ASPECT  
 Different methods are available in literature
313-316
 for  the preparation of 
quinoxalines. The popular methods are :  
(1) M. L. Keshtov and co-worker
317
 have been prepared dimer type quinoxaline 
derivatives (II).  
NN
ArAr
NO
2
(II)  
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(2) Quinoxaline derivative
318
 (III) are prepared by reaction of Nitrobenzene with 
NH2OR in presence of Cu catalyst  and reaction of nitroanilines and presence 
of hydrogenation catalyst.  
N
NX
Y
R''
R'
(III)  
(3) S K. Kanungo et. al.
319
 have prepared 1, 3-Dimethylpyrrolo quinoxaline-2-
ones from chloroacetic acid and o-phenylene diamine.  
 
THERAPEUTIC IMPORTANCE  
 Quinoxaline derivatives have been found to possess wide range of terapeutic 
activities.  
 
1. Inhibition of Candida albicans
320
 
2. CNS depressant
321-322
 
3. Antitubercular
323
 
4. Antiulcer
324-325
 
5. Analgesic
326
 
6. Anxiolytic
327
 
7. Antihypertensive
328
 
8. Antitumor
329
 
9. Cardiovascular
330
 
10. Herbicidal
331
 
11. Antifungal
332
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 1-(Aminoalkyl)-3-quinoxaline-2-one derivatives were prepared as 
neuroprotective agents by K. Ehrenberger and F. Dominik
333
. A new series of 
sulphonamido quinoxaline were synthesised and assessed for various biological 
activity
334
, antibiotics action of some novel quinoxaline derivative were studied by  
T. V. Alfreson
335 
and  co-workers.  
 
 V.Gabriella and co-workers
336
 have formulated some new quinoxaline. 
derivative (IV) as in vitro anticancer activity.  
N
N Y
X
OR''
R'''
R'
(IV)  
 Recently, serveral co-workers have been prepared quinoxaline derivatives by 
different methods which possess AMPA receptor antagonist and antihistaminic 
337-339
, 
antagonist
340-341
, human dopamine D4 receptor
342
, antibacterial
343
, antimicrobial
344-346
, 
anticancer
347
, and antitumor
348
 activities.  
 
 More recently, B. Konig et al.
349
 have synthesised quinoxaline derivatives 
which has activation of PPARa and PPAR gamma reduces triacyglycerol G. 
Sarodirick, T. G. Linker et al.
350
 have prepared quinoxaline. derivatives having 
bactericidal, algecide, fungicide activity for agriculture use. Quinoxaline derivative 
used PDGE receptor and LCK tyrosine kinase inhibitors.  
 
 In order to achieve better therapeutic agent, the preparation of quinoxaline 
derivatives has been taken as under.  
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SECION : I : SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF [2"-
ARYL(QUINOXALINE)-3-YL]-(METHYLENE PHENYL 
AMINO)-6-[BIS(2"'-CHLOROETHYL)AMINO]-4-
METHOXY-1,3,5-TRIAZINE.  
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SECTION : I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF [2"-
ARYL(QUINOXALINE)-3-YL]-(METHYLENE PHENYL AMINO)-6-[BIS-
(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
 Quinoxalines have been found to possess wide range of therapeutic activities 
and industrial importance. In view of getting [2"-aryl-(quinoxaline)-3-yl]-(methylene 
phenyl amino)-6-[Bis(2"'-chloroethyl-amino]-4-methoxy-1,3,5-triazine of Type-(XIV) 
have been synthesised by the condensation of 2-{4'-[(3"-aryl)-2"-propene-1"-one]-
phenylamino}-6-[Bis(2"'- chloroethyl amino]-4-methoxy-1,3,5-triazine. of Type-(I) 
with bromine in glacial actetic acid and o-phenylenediamine.  
R
N
N
NCl
N
N
NCl
O
N
H
(Type-XIV) R = Aryl  
 The constitution of the products have been charactrised by elemental analysis 
IR, 
1
H NMR,  Mass spectral study. The  products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the Part : I, Section I, Page No. 39-41. 
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IR SPECTRAL STUDY OF [2"-(4""-METHOXYPHENYL) (QUINOXALINE)-
3YL]-(METHYLENE PHENYL AMINO)-6-[BIS(2"'-CHLORO ETHYL) 
AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Instrument : SHIMADZU-FT-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Quinoxalines 
 
C-H  Str.(sym) 
C-H  Str.( sym) 
C-H  def.(sym) 
C-H  def.( sym) 
-CH2  Str. 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=N  Str. 
C-N  Str. 
2900 
2881 
1450 
1369 
1450 
3058 
1265 
800 
1487 
1070 
1598 
3315 
1558 
1265 
1070 
800 
1608 
1089 
 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
1485-1445 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1630-1590 
1220-1020 
 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF [2"-(4""-METHOXYPHENYL) 
(QUINOXALINE)-3YL]-(METHYLENE PHENYL AMINO)-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Internal standard : TMS; solvent : DMSO ;  Instrument : DMSO spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
 
3.60-4.00 
7.94-7.98 
8.07-8.40 
4.10-4.14 
2.77 
10.23 
3.37 
7.28-8.07 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
4 H 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Singlet 
Multiplate 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
Ar-H g 
Ar-H i 
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MASS SPECTRAL STUDY OF [2"-"-(4""-METHOXYPHENYL) (QUINOXALINE)-3-YL]-(METHYLENE PHENYL AMINO)-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 590) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 2-OH C6H4 (24) C6H5 (19) 3-OH C6H4 (21) 4-OH C6H4 (22) 4-OH, 3OCH3 C6H4 (20) 
 4-OH C6H4 (23) 4-OH C6H4 (21) 4-Br C6H4 (20) 4-OCH3 C6H4 (23) 4-NO2 C6H4 (23) 
 4-NO2 C6H4 (21) 3NO2 C6H4 (19) 4-N,N (CH3)2 4-NO2 C6H4 (21)  
  4-NO2 C6H4 (21) C6H4 (22)   
      
   Comparable activity with known standard drugs  
Ampicilin              50 µg 23 18 17 27 - 
Chloramphenicol     “ 24 19 25 26 - 
Norfloxacin             “ 24 19 25 26 - 
Greseofulvin              “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
N
N
NCl
N
N
NCl
O
N
H
NH
2
NH
2
(Type-XIV) R = Aryl
Br2
gl. CH3COOH
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF [2"-ARYL(QUINOXALINE)-3YL]-(METHYLENE PHENYL 
AMINO)-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-
TRIAZINE. 
 
(A) Synthesis of 2-(4'-Acetylphenyl amino)-4, 6-dichloro-1,3,5-triazie. 
 For synthesis, see Part-I, Section-I, Page No. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis (2"-chloro ethyl) amino]-4- 
methoxy-1,3,5-triazine.  
 For Synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"- propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page No. 36-38. 
 
(E) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2", 3"-dibromo-1"-one] 
phenyl amino}-6-[Bis (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 A chalcones of Type (I) 0.01 M was dissoved in acetic acid (30 ml) a bromine 
in acetic acid (1 ml) 10% was slowly added to it. The reaction mixture was 
stirred for 2 hrs. It was poured into water and crystallized from methanol. 
Yellow needles obtained.  
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(F) Synthesis of [2"-(4""-Methoxy phenyl)-(quinoxaline)-3-yl]-(methylene 
phyenyl amino)-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine. 
 
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)2", 3"- dibromo-1"-one] phenyl 
amino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine ( 6.60 gm, 
0.01 M) and o-phenylene diamine (1.08 gm, 0.01 M) taken in methanol (25 
ml). A few drops of conc. H2SO4 was added. The reaction mixture was heated 
at 90º C. for 1 hr. in water bath. The reaction mixture poured into crushed ice, 
filtered, dried and crystallised from dioxane. Yield : 69%, M. P. 239º C (Found 
C : 61.00; H : 4.89; N : 16.58; C30H29O2N7Cl2 required C : 61.01; H : 4.91; N : 
16.60%).  
  Simillarly other compounds were prepared and their physical data 
recorded intable no.27 
(F) Antimicrobial activity of [2"-Aryl (quinoxaline)-3-yl]-(methylene phenyl 
amino)-6-[Bis(2"'-chloroethyl) amino]-4- methoxy-1,3,5-triazine.  
 
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page no. 39-41.  
 The zone of inhibition of the test solutions are recorded in Table no. 28. 
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TABLE NO : 27 : PHYSICAL CONSTANTS OF [2"-ARYL(QUINOXAINE)-3YL]-(METHYLENE PHENYL AMINO)-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C294H27Cl2N7O 199 80 17.49 17.45 
2. 2-OH C6H4 C29H27Cl2N7O2 204 76 17.01 17.01 
3. 3-OH C6H4 C29H27Cl2N7O2 175 73 17.01 16.99 
4. 4-OH C6H4 C29H27Cl2N7O2 181 75 17.01 17.00 
5. 4-OCH3 C6H4 C30H29Cl2N7O2 239 69 16.60 16.58 
6. 4-OH, 3-OCH3 C6H3 C30H29Cl2N7O3 203 79 16.17 16.12 
7. 4-Br. C6H4 C29H26BrCl2N7O 212 73 15.33 15.31 
8. 3-NO2 C6H4 C29H26Cl2N8O3 159 78 18.51 18.49 
9. 4-NO2 C6H4 C29H26Cl2N8O3 173 81 18.51 18.45 
10 4-N,N(CH3)2 C6H4 C31H32Cl2N8O 198 70 18.57 18.56 
11. C4H3O (Furfuryl) C27H25Cl2N7O2 179 78 17.81 17.80 
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TABLE NO : 28 : ANTIMICROBIAL ACTIVITY OF [2"-ARYL(QUINOXALINE)-3YL]-(METHYLENE PHENYL AMINO)-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 15 19 16 20 15 
2 2-OH C6H4 24 18 17 18 17 
3 3-OH C6H4 20 17 21 19 16 
4 4-OH C6H4 23 20 18 22 18 
5 4-OCH3 C6H4 12 16 17 23 19 
6 4-OH, 3-OCH3 C6H3 17 15 16 18 17 
7 4-Br. C6H4 16 14 20 17 20 
8 3-NO2 C6H4 15 19 18 19 18 
9 4-NO2 C6H4 21 21 19 21 23 
10 4-N,N(CH3)2 C6H4 20 17 22 15 18 
11 C4H3O (Furfuryl) 18 15 15 17 19 
 209 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART - VIII 
STUDIES ON BARBITONES 
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STUDIES ON BARBITONES 
INTRODUCTION  
 The emerging role of barbitones in pharmaceutical chemistry as well as in 
biochemistry stimulated temendous interest in the synthesis of barbitones of therapetic 
interest. Most important is the effect of barbiturates on the central nervous system. 
Barbituric acid derivatives constitute an important class of compounds possessing 
diverse type of biological properties including hypnotic, sedative, anticonvulsant, 
cardiovascular etc.  
 Barbituric acid derivatives are perhaps the most widely used pyrimidines in 
medicine. Veronal (I) and Luminol (II) possess hypnotic activities, while pentothiol 
(III) is used as an anaesthetic.  
N
H
NH
O
O
O N
H
NH
O
O
O N
H
NH
O
O
O
(I) (II) (III)  
SYNTHETIC ASPECT  
 Different methods for the synthesis of barbitones have been described in 
literature
351-355
 
1. M. R. Mahmoud et al.
356
 have synthesized barbituric acid derivatives from 
chalcones.  
R
O
R'
NH NH
O O
O
NH NH
O O
O
R R'
+
gla. acetic acid
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2. Cao-Yun et al.
357
 have prepared barbituric acid derivatives by the reaction of 
different aldehydes with barbituric acid in basic media.  
NH NH
O O
O
NH NH
O O
O
R
OR
HO-
+
 
3. R. K. Roy et al.
358
 have synthesised barbituric acid derivatives by the reaction 
of urea derivatives with malonic acid.  
 
THERAPEUTIC IMPORTANCE :  
 At present time great interet is being taken in barbituric acid derivative 
because of its biological activity and their relation with nucleic acids, viz uracil, 
thymine and cytosine.  
 
 Some barbiturates showing cardiovascular
359-360
 antiinflammatory
361
 and 
pesticidal
362
 activities have been reported. D. Peters et al
363
 they have synthesised 
some uracil derivatives and screened for antiviral activity. R. Raymond et al
364
 
synthesised some barbiturates (IV) which showed anticancer activity.  
NH
NH
R
O
O
O
N
H
N
S O
N
N
H
O
R
O O
O
Ph
(IV) (V)  
 Several co-workers have synthesised barbitone derivatives and reported their 
antagonist
365
, antitumor
366
, anticonvulsant
367
 and metalloproteinas inhibitor
368
 
activities.  Abdel-Hamide and co-workers
369
 have prepared barbituric acid derivatives 
(V) having anticonvulsant activity. A. N. Shivanyuk at al.
370
 have demonstrated 
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barbitone derivatives as porphyrin melamine calixarene receptor. Wolf-Gange et al.
371
 
have reported 5-(3-benzylthiazolidine-2-ylidene)- 1, 3-dimethyl hexahydro 
pyrimidine-2,4, 6-trione having agricultural activity. Some barbituric acid derivatives 
used as herbicides and insecticides have been demonstrated.
372
 
 
 M. T. Omar
373
 has synthesised barbitone derivatives showing antimicrobial 
activity. Sakai et al.
374
 have synthesised some new barbitones which were assessed for 
bone and cartilage disease. F. Grams and G. Zimmermantv
375
 have prepared 
barbitones as metalloprotease inhibitors. Some barbitone derivatives have been 
studied for their antitumor activity
376
. 
 
 Moreover, isotylidene barbiturates (VI) showing antibacterial activity have 
been synthesised
377
. D. Geppert and co-workers
378
 have prepared new pyrimidine-
2,4,6-triones (VII) as metalloproteinase inhibitors.  
N
N
NH NH
O O
O
OCl
OH
OH
NH
NHNH
O O
O
OR
(VII)(VI)  
 Keeping in view the important biological activities possessed by barbituric 
acid derivatives, we have tried to synthesise some new barbitones having better 
biological activities.  
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SECTION : I  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-
[(3"-ARYL)-2"-PROPENE-1"-BARBITURIC ACID]-
PHENYLAMINO} - 6 - [BIS (2"'-CHLOROETHYL)-
AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
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SECTION : I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-
PROPENE-1"-BARBITURIC ACID]-PHENYLAMINO}-6-[BIS (2"'-
CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
 Barbituric acid derivatives are wide spectrum of biological activities. Bis (2-
chloroethyl) amine, 1,3,5-triazine molecules possess diversified anticancer, anti-HIV 
and other therapeutic activity with a view of 2-{4'-[(3"-Aryl)-2"-propene-1"-barbituric 
acid]-phenyl amino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5- triazine of 
Type (XV) have been synthesised by the reaction of 2-{4'-[(3"-aryl)-2"-propene-1"-
one]-phenyl amino}-6-[Bis(2"'- chloroethyl) amino]-4-methoxy-1,3,5- triazine of 
Type-(I) with barbituric acid in glacial acetic acid.  
NH NH
R
NCl
N
N
NCl
O
N
H
O
O
O
(Type-XV) R = Aryl
 
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR,  and Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the Part : I, Section : I, Page no. 39-41. 
 215 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
IR SPECTRAL STUDY OF 2-{4'-[(3"-4""-METHOXYPYENYL)-2"-
PROPENE-1"-BARBITURIC ACID]-PHENYLAMINO}-6-[BIS (2"'-
CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Instrument : SHIMADZU-FT-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Barbitones 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Bending 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
N-H Str. 
C=O  Str. 
C=C  Str. 
2948 
2872 
1458 
1373 
1458 
3095 
1224 
823 
1508 
1124 
1598 
3374 
1571 
1214 
1068 
767 
3348 
1670 
1544 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
1470-1440 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
3350-3250 
1750-1610 
1600-1450 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[3"-(4""-METHOXYPHENYL) -2"-
PROPENE-1"-BARBITURIC ACID]-PHENYLAMINO}-6-[BIS (2"'-
CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Internal standard : TMS; solvent : DMSO ; Instrument : DPX-200 spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
 
3.70-4.00 
7.35-7.37 
8.00-8.28 
4.05-4.20 
2.84 
9.79-10.30 
5.13-5.18 
 
6 H 
4 H 
4 H 
4 H 
4 H 
3 H 
2 H 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Doublet  
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-CH=CH g 
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MASS SPECTRAL STUDY OF 2-{4'-[3"-(4""-METHOXYPHENYL) -2"-PROPENE-1"-BARBITURIC ACID]-PHENYLAMINO}-6-
[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE. (M.W. : 612) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in 
m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 2-OH C6H4(21) 4-OH C6H4(18) 2-OH C6H4(22) 4-OH C6H4(21) C6H5(21) 
 3-OH C6H4(23) 4-OCH3 C6H4(19) 3-OH C6H4(25) 4-OH, 3OCH3,  4-OH C6H4(22) 
 4-Br C6H4(22) 4-NO2 C6H4(18) 4-OCH3 C6H4(21) C6H3(22) 3-NO2 C6H4(22) 
   4-N,N(CH3)2   
   C6H4(23)   
 
Comparable activity with known standard drugs 
 
Ampicilin              50 µg 23 18 17 27 - 
ChlorAmphenicol     “ 24 19 25 26 - 
Norfloxacin             “ 24 19 25 26 - 
Greseofulvin              “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
NH NH
R
NCl
N
N
NCl
O
N
H
O
O
O
NH NH
O
O
O
(Type-XV)   R = Aryl
gl. CH3COOH
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-BARBITURIC ACID]-
PHENYLAMINO}-6-[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-
1,3,5-TRIAZINE.  
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3, 5-
triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"chloro ethyl) amino]-4- 
methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Pagen no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxyphenyl)-2"-propene-1"-one] phenyl 
amino}-6-Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 For systhesis, see Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-barbituric 
acid]-phenyl amino}-6-[Bis-(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-
triazine.  
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 A mixture of 2-{4'-[3"-(4""-methoxyphenyl)2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-choroethyl) amino]-4-methoxy-1,3,5-triazine (5.02 gm, 
0.01M); barbituric acid (1.28 gm, 0.01M) and gla. aceticacid in methanol, the 
reaction mixture was refluxed 12 hrs. at 100° C. temp. The content was 
poured into crushed ice, filtered, dried and crystallised from dioxane. Yield : 
75%, M. P. 165 C (Found : C 54.89; H : 4.40; N : 16.00, C28H27O5N7Cl2 
required C:54.90;  H:4.41; N:16.01 %) 
  similaraly other compound were synthesised and their physical data 
recorded in Table no. 29.  
 
(F) Antimicrobial activity of 2-{4'-[(3"-aryl)-3"-propene-1"-barbituricacid]-
phenyl amino}-6-[Bis (2"-chloro ethyl-amino]-4- methoxy-1,3,5- triazine.  
 
The antimicrobial testing was carried out as described in Part : I, Section : I, 
Page No. 39-41.  
 
 The zone of inhibition of the test solution are recorded in Table No. 30. 
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TABLE NO : 29 : PHYSICAL CONSTANTS OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-BARBITURIC ACID]-PHENYLAMNI}-6-[BIS 
(2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1 2 3 4 5 6 7 
1. C6H5 C27H25Cl2N7O4 201 58 16.83 16.80 
2. 2-OH C6H4 C27H25Cl2N7O5 238 60 16.38 16.35 
3. 3-OH C6H4 C27H25Cl2N7O5 265 65 16.38 16.32 
4. 4-OH C6H4 C27H25Cl2N7O5 222 70 16.38 16.30 
5. 4-OCH3 C6H4 C28H27Cl2N7O5 165 75 16.01 16.00 
6. 4-OH, 3-OCH3 C6H3 C28H27Cl2N7O6 201 72 15.60 15.55 
7. 4-Br. C6H4 C27H24BrCl2N7O4 125 76 14.83 15.81 
8. 3-NO2 C6H4 C27H24Cl2N8O6 165 58 17.86 17.83 
9. 4-NO2 C6H4 C27H24Cl2N8O6 117 81 17.86 17.82 
10 4-N,N(CH3)2 C6H4 C29H30Cl2N8O4 192 69 17.91 17.89 
11. C4H3O (Furfuryl) C25H23Cl2N7O5 185 73 17.13 17.09 
 
 223 
 
Synthesis, spectral studies and therapeutic activity of some Heterocyclic compounds 
TABLE NO : 30 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-BARBITURIC ACID]-PHENYLAMNI}-6-
[BIS (2"'-CHLOROETHYL)-AMINO]-4-METHOXY-1,3,5-TRIAZINE.  
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 20 12 19 18 21 
2 2-OH C6H4 21 14 22 17 18 
3 3-OH C6H4 23 15 25 16 19 
4 4-OH C6H4 18 18 20 21 22 
5 4-OCH3 C6H4 17 19 21 19 16 
6 4-OH, 3-OCH3 C6H3 15 15 16 22 15 
7 4-Br. C6H4 22 15 18 15 14 
8 3-NO2 C6H4 18 14 17 14 22 
9 4-NO2 C6H4 19 18 19 19 18 
10 4-N,N(CH3)2 C6H4 16 13 23 20 19 
11 C4H3O (Furfuryl) 15 12 18 18 20 
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STUDIES ON THIOSEMICARBOXIMIDES 
INTRODUCTION  
 Thiosemicarbazone derivatives are of special importance because of their 
versatile biological and pharmacological activities. Thiosemicarbazone derivatives 
have found applications in drug development for the treatment of central nervous 
system disorders, of bacterial infections, as well as analgesic and antiallergic agent. 
They are potent intermediates for the synthesis of pharmaceutical and bioactive 
materials.  
 
 The clinically active drug methisazone and related compounds have shown 
activity against DNA viruses, principally the orthopoxviruses, both in vitro and in 
vivo.  
N
O
N
NH
SNH
2
 
SYNTHETIC ASPECT  
 Nowadays reaction between thiosemicarbazide with ketones or aldehydes have 
attracted a great attention, because of their interesting nature of resulting compounds 
for their applications and biological activities.  
 
 Different methods are used for the synthesis of thiosemicarbazones which are 
described in literature
379-382
.  
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1. A. B. Tomchin
383
 has synthesised thiosemicarbazones by the recyclisation of 
2-amino-5-(2-aminoaroyl)-1,3,4-thiadiazoles.  
S
N
N
R
R'
NH
2
O
NH
R''
HOAC
NH
N
N
H
N
H
S
R''
R
R'
 
2. Y. Perumal and co-workers
384
 have prepared thiosemicarbazones by the 
condensation of 6-chlorobenzothiazolyI-2-thiosemicarbazide with aldehydes 
or ketones.  
S
N
Cl
N
H
N
H
S
NH
2
S
N
Cl
N
H
N
H
S
N R'
R
Aldehyde / 
  Ketone
gla. acetic acid
 
THERAPEUTIC IMPORTANCE : 
 Thiosemicarbazones exhibit a wide variety of biological activities which are 
listed as under.  
1. Antibacterial
385
 
2. Anthelmintic
386
 
3. Antifungal
387
 
4. Anticonvulsant
388
 
5. Antirheumatics
389
 
6. Antiherpes
390
 
7. Antimalarial
391
 
8. Antitumor
392-393
 
9. anticancer
394
 
 
 Antimicrobial activity of thiosemicarbazone derivatives have been reported 
395-396
,  T. Siatra et al.
397 
have synthesised some new thiosemicarbazones from 3-acetyl 
indole and reported its effect on DNA synthesis and cell proliferation. 5-chloro 
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salicyaldehydic thiosemicarbazone derivatives have been documented by Z. 
Quianawin et al.
398
 
 
 N-substituted thiosemicarbazones showing antitumor activity have been 
reported
399
. D. Wang et al.
400
 patented thiosemicarbazones useful as sodium channel 
blockers. K. I. Zabella
401
 has prepared thiosemicarbazones (I) from 1, 3-cyclic 
diamino and reported as anticancer agent. O. V. Fedorova et at.
402
 synthesised some 
thiosemicarbazones (II) having potent in vitro tuberculostatic activity.  
NH
NH
N N
H
N
H
S
R O
O
O
N
N
H
NH
2
S
N
N
H
NH
2
S
(I) (II)  
 Some 3-aminopyrimidine 2-carboxaldehyde thiosemicarbazone derivatives are 
reported as novel prodrug forms of ribonucleotide reductase inhibitors 3-AP and 3-
AMP by Li Jun et al.
407
 
 
 Some new thiosemicarbazone derivatives have been studied for their 
anticancer activity
404
 D. Sharma et al.
405
 have synthesised thiophene 2-
carboxaldehyde thiosemicarbazones and evaluated their antimicrobial and antiviral 
activity. S.P.R. Rodiriguez and co-workers
406
 have synthesised 4-substituted 
thiosemicarbazones and reported its antiproliferartive activity. Thiosemicarbazone 
derivatives as potent antiviral agents have been investigated G. E. Iniama et al
407
 
 
 Moreover, Jin Shuhui and co-workers
408
 thiosemicarbazones and prepared 
thiosemicarbazones and reported them for antifungal activity. Thiosemicarbazones 
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(III) showing significant antimicrobial activity are described
409
. Nilgun K. 
410
 have 
synthesised some thiosemicarbazones (IV) bearing indol nucleus and evaluated their 
cytotoxicity.  
N
H
F F
N
NH
SNH
2
NH
O
N
NH
N
H
S
R
O
2
N
(III) (IV)  
 Due to the physiological and biological activities of thiosemicarbazones, it 
was contemplated to synthesis some new thiosemicarbazones with a hope that these 
compounds may have better pharmacological activities.  
 
SECTION - I :  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(3"ARYL)-2"-PROPENE-1"-
THIOSEMICARBOXIMIDE] -PHENYL AMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO] – 4 -  METHOXY-
1,3,5-TRIAZINE.  
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SECTION : I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-
PROPENE-1"-THIOSEMICARBOXIMIDE]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE.  
 
 Thiosemicarboximaides derivatives possess broad spectrum of therapeutic 
activity e.g. antidiabectic, antimicrobial, anticonvulsant, antipyretic etc., with a view 
of above facts 2-{4'-[(3"-aryl)-2"-propene-1"-thiosemicarboximides]-phenyl amino}-
6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine of Type. (XVI) have been 
synthesised by the reaction of 2-{4'-[(3"-aryl)-2"-propene-1"-one]-phenyl amino}-6-
[Bis(2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine, chalcones of Type (I) with 
thiosemicarbazide in alcohol.  
R
N
NCl
N
N
NCl
O
N
H
N
H
NH
2
S
(Type-XVI) R = Aryl
 
 The constitution of the products have been characterised by elemental analysis 
IR, 
1
H NMR, and Mass spectral study. The products were screened for antimicrobial 
activity at a concentration of 50 µg.  
 
 The details have been cited in the part : I, Section : I, Page no. 39-41. 
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IR SPECTRAL STUDY OF 2-{4'-[(3"-(4""-METHOXYPHENYL)-2"-
PROPENE-1"-THIOSEMICARBOXIMIDE]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE.  
 
Instrument : SHIMADZU-FT-IR-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed Reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Thiosemi 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C=N  Str. 
C-N  Str. 
C=S  Str. 
2929 
2878 
1465 
1361 
3073 
1170 
840 
1475 
1029 
1623 
3447 
1623 
1249 
1029 
773 
1647 
1361 
1575 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1650-1630 
1380-1332 
1590-1550 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[(3"-(4""-METHOXYPHENYL)-2"-
PROPENE-1"-THIOSEMICARBOXIMIDE]-PHENYL AMINO}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE.  
 
Internal standard : TMS; solvent : DMSO ;  Instrument : BRUKER spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
9 
 
3.95-3.98 
7.23-7.71 
8.60 
3.96-3.98 
2.25-2.84 
8.60 
3.98 
9.02 
9.11 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
1 H 
2 H 
 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Doublet  
Singlet 
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-CH=CH g 
-N-NH h 
-NH2 i 
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MASS SPECTRAL STUDY OF 2-{4'-[3"-(4""-METHOXYPHENYL) -2"-PROPENE-1"-THIOSEMICARBOXIMIDE]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE. (M.W. : 575) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
Antifungal activity 
Zone of inhibition in m.m. 
 B. mega. 
R 
B. subtillis 
R 
E. coli. 
R 
P. fluorescens. 
R 
A. awamori. 
R 
 4-OH C6H4(22) 4-OH C6H4(20) 3-OH C6H4(23) C6H5(21) 3-OH C6H4(22) 
 4-NO2 C6H4(26) 3-NO2 C6H4(23) 4-OH C6H4(20) 4-OH C6H4(20) 4-NO2 C6H4(24) 
   4-Br C6H4(22) 4-Br C6H4(22) 4-N,N (CH3)2 C6H4(23) 
      
Comparable activity with known standard drugs 
 
Ampicilin             50 µg. 23 18 17 27 - 
ChlorAmphenicol    ” 24 19 25 26 - 
Norfloxacin            ” 24 19 25 26 - 
Greseofulvin            ” - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
R
N
NCl
N
N
NCl
O
N
H
N
H
NH
2
S
(Type-XVI) R = Aryl
Thiosemicarbezide
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2 - { 4' - [(3"-ARYL) - 2" – PROPENE - 1" –
THIOSEMICARBOXIMIDE] - PHENYL AMINO} – 6 - [ BIS ( 2"' - CHLORO 
ETHYL )  AMINO ] – 4 -  METHOXY - 1, 3, 5 - TRIAZINE.  
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,3,5-triazine.  
 For  synthesis, see Part : I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1.3,5- 
triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-Methoxyphenyl)-2"-propene-1"-one]phenyl 
amino}-6- [Bis. (2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis See Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-
thiosemicarboximide]- phenyl amino}-6-[Bis(2"'-chloro ethyl) amino]-4-
methoxy-1,3,5- triazine.  
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 A mixture of 2-{4'-[3"-(4""-Methoxy phenyl)-2"-propene-1"-one]phenyl 
amino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5, triazine (5.02 gm, 
0.01 M); thioseimicarbazide (0.91 gm, 0.01 M) and alcoholic KOH, the 
reaction mixture was refluxed for 10 hrs. at 100º C. temp. The reaction 
mixture poured into crushed ice, filtered,dried, and crystallised from dioxane, 
yield : 76%, M.P. : 143º C. (Found : C : 52.70;, H : 4.83; N : 19.43; 
C25H28O2N8Cl2S required  C : 52.17; H : 4.86; N : 19.47%) 
  Similarly other compounds were prepared and their physical data 
recorded in Table no.31. 
 
(F) Antimicrobial activity of 2-{4'-[(3"-aryl)-2"-propene-1"-
thiosemicarboximide]-phenyl amino}-6-[Bis. (2'"-chloro ethyl)- amino]-4- 
methoxy-1,3,5-triazine,  
 
The antimicrobial testing was carried out as described in Part : I, Section : I, 
Page no. 39-41. 
 
 The zone of inhibition of the test solution are recorded in Table No. 32. 
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TABLE NO : 31 : PHYSICAL CONSTANTS OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-THIOSEMICARBOXIMIDES]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE.  
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C24H26Cl2N8O S 191 58 20.54 20.51 
2. 2-OH C6H4 C24H26Cl2N8O2 S 201 70 19.96 19.90 
3. 3-OH C6H4 C24H26Cl2N2O2 S 229 69 19.96 19.92 
4. 4-OH C6H4 C24H26Cl2N8O2 S 178 81 19.96 19.94 
5. 4-OCH3 C6H4 C25H28Cl2N8O2 S 143 76 19.47 19.43 
6. 4-OH, 3-OCH3 C6H3 C25H28Cl2N8O3 S 157 77 18.94 18.89 
7. 4-Br. C6H4 C24H25BrCl2N8O S 111 82 17.95 17.90 
8. 3-NO2 C6H4 C24H25Cl2N9O3 S 135 68 21.35 21.31 
9. 4-NO2 C6H4 C24H25Cl2N9O3 S 218 65 21.35 21.32 
10 4-N,N(CH3)2 C6H4 C26H31Cl2N9O S 203 71 21.42 21.41 
11. C4H3O (Furfuryl) C22H24Cl2N8O2 S 115 75 20.93 20.98 
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TABLE NO : 32 : ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-THIOSEMICARBOXIMIDE]-PHENYL 
AMINO}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4- METHOXY-1,3,5-TRIAZINE.  
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 15 17 14 21 19 
2 2-OH C6H4 17 19 17 17 20 
3 3-OH C6H4 18 14 23 19 22 
4 4-OH C6H4 22 20 20 24 21 
5 4-OCH3 C6H4 18 12 18 19 19 
6 4-OH, 3-OCH3 C6H3 15 15 17 18 17 
7 4-Br. C6H4 17 17 22 17 14 
8 3-NO2 C6H4 19 23 18 15 17 
9 4-NO2 C6H4 26 14 17 22 24 
10 4-N,N(CH3)2 C6H4 15 15 15 16 23 
11 C4H3O (Furfuryl) 13 17 14 15 16 
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PART - X 
STUDIES ON TRIAZOLES 
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STUDIES ON TRIAZOLES 
 
INTRODUCTION  
 Triazole derviatives are of special importance because of their versatile 
biological and pharacological activities. Triazole derivatives have been found plant 
growth regulator, herbicide, fungicide, analgesic and antiallergic agent. They are 
potent intermediates for the synthesis of pharmaceutical and bioactive materials.  
 
 The clinically active drug Fluconazole
411
 represent under :  
N
N
N
N
N
N
F
F
OH
 
SYNTHETIC ASPECT :  
 Nowadays reaction between triazole with on their substituent to produce new 
biologically acitve compounds.  
 
1. B. Buttler
412
 have been synthesised 1-{[2-(2"-dicholrophenyl)-4-propyl-1,3-
dioxo-2-yl] methyl]-1H-1,3,4-triazole "Propiconazole". as a antifungal agents.  
O
O
N
N
N
Cl
Cl
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2. Wiley et al.
413
 have been reported 1-ter. butyl -2-(p-chloro benzyl)-2-(1,3,4-
triazol-1-yl)-ethanol as a plant growth regulartor.  
N
N
N
Cl
OH  
3. S. V. Overton et al
.414
 have been reported 1-(biphenyl-4-yl oxy)-3,3-dimethyl-
1-(1H-1,3,4-triazle-1-yl)-butan-2-ol "Bitertanol" as agricultural fungicide.  
N
N
N
O
OH  
THERAPEUTIC IMPORTANCE :  
 Thriazole exhibit a wide range variety of biological acitvitiews which are 
listed as under.  
1. Fungicide
415-416
 
2. Antideprassant
417
 
3. Coronary vasodilator
418
 
4. Sedative, hypnofic
419
 
5. anti viral
420
 
6. antiallergic
421
 
 
 Due to the physiological and biological activities of possessed by triazoles 
derivatives, we have tried to synthesis some new triazoles having better biological 
activities.  
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SECTION - I :  SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-
{4'-[(3"-ARYL)-2"-PROPENE-1" – N - ( 1,2,4 - 
TRIAZOLE) AMINO]} – 6 - [BIS(2"'-CHLORO ETHYL) 
AMINO] – 4 –METHOXY - 1, 3, 5-TRIAZINE.  
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SECTION - I 
 
SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF 2-{4'-[(3"-ARYL)-2"-
PROPENE-1"-N-(1,2,4-TRIAZOLE) AMINO]}-6-[BIS(2"'-CHLORO ETHYL) 
AMINO]-4-METHOXY-1, 3, 5-TRIAZINE.  
 
 Triazole derivatives possess wide spectrum of therapeutic activity such as 
antifungal, anticonvalusant, antibacterial etc. In view of getting 2-{4'-[(3"-aryl)-2"-
propene-1"-N-(1,2,4-triazole) amino]}-6-[Bis(2"'-chloro ethyl)] amino-4-methoxy-
1,2,4-triazine of Type (XVII) have been synthesised by the reaction of 2-{4'-[(3"-
aryl)-2"-propene-1"-one]-phenyl amino}-6-[Bis(2"'-chloroethyl)] amino -4- methoxy-
1,3,5 - triazine with 4-amino -1,2,4 - triazole in alcohol.  
N
R
N
NCl
N
N
NCl
O
N
H
N
N
(Type-XVII) R = Aryl
 
 The constitution of the products have been chaoracterised by elemental 
analysis. IR, 
1
H NMR, and Mass spectral study. The products were screended for 
antimicrobial activity at a concentration of 50 µg.  
 
 The details have been cited in the Part-I, Section-I, Page no. 39-41.  
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IR SPECTRAL STUDY OF 2-{4'-[3"-(4""-METHOXYPHENYL) -2"-
PROPENE-1"-N-(1,2,4-TRIAZOLE) AMINO]}-6-[BIS(2"'-CHLORO ETHYL) 
AMINO]-4-METHOXY-1, 3, 5-TRIAZINE.  
 
Instrument : SHIMADZU-FT-8400, Spectrophoto meter frequency range : 4000-400 cm
-1
 (KBrdisc)  
Type Vibration Mode Frequency in cm
-1
 Ref. 
observed reported 
Alkane 
 
 
 
Aromatic 
 
 
 
S-triazine 
 
Amine 
 
Ether 
 
Halide 
Triazole 
 
C-H  Str.(asym) 
C-H  Str.( sym) 
C-H  def.(asym) 
C-H  def.( sym) 
C-H  Str. 
C-H  i.p. def 
C-H  o.o.p. def 
C=C  Str. 
C-N  Str. 
C=N  Str. 
N-H Str. 
N-H  Bending 
C-O-C  Str.(asym) 
C-O-C  Str.(sym) 
C-Cl  Str. 
C-N  Str. 
N-N  Str. 
C=N  Str. 
C-N  Bending  
2947 
2889 
1444 
1363 
3024 
1101 
830 
1450 
1149 
1581 
3413 
1550 
1215 
1047 
792 
1676 
1581 
1598 
1298 
2990-2850 
2880-2860 
1470-1435 
1390-1360 
3090-3030 
1300-1100 
832-800 
1600-1450 
1220-1020 
1630-1590 
3500-3310 
1650-1550 
1260-1220 
1075-1020 
800-600 
1690-1640 
1630-1575 
1630-1593 
1340-1250 
422 – 423 
” 
” 
” 
” 
” 
” 
” 
” 
” 
” 
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NMR SPECTRAL STUDY OF 2-{4'-[3"-(4""-METHOXYPHENYL) -2"-
PROPENE-1"-N-(1,2,4-TRIAZOLE) AMINO]}-6-[BIS(2"'-CHLORO ETHYL) 
AMINO]-4-METHOXY-1, 3, 5-TRIAZINE.  
 
Internal standard : TMS; solvent : DMSO ;  Instrument : DPX-200 spectrometer (300 MHz) 
Signal 
No. 
Signal Position 
(ppm) 
Relative no. of 
protons 
Multiplicity Inference 
1 
2 
3 
4 
5 
6 
7 
8 
 
3.71-3.86 
7.66-7.79 
7.99-8.12 
4.79-4.84 
2.50-2.89 
9.87-9.96 
4.81-4.84 
7.01-7.03 
 
6 H 
4 H 
4 H 
4 H 
4 H 
1 H 
2 H 
2 H 
 
 
 
Singlet 
D. Doublet 
D. Doublet 
Triplet 
Triplet 
Singlet 
Doublet  
Singlet 
 
Ar-OCH3 
Ar-Hb 
Ar-Hc 
-CH2-Cl 
-N-CH2- 
Ar-NHf 
-CH=CH g 
Ar-H h 
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MASS SPECTRAL STUDY OF 2-{4'-[(3"-(4""-METHOXYPHENYL) -2"-PROPENE-1"-N-(1,2,4-TRIAZOLE) AMINO]}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1, 3, 5-TRIAZINE.  (M.W. : 584) 
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Antimicrobial Activity : 
Conclution :  
Maximum antimicrobial activity :  
 Antibacterial activity 
Zone of inhibition in m.m. 
 
Antifungal activity  
Zone of inhibition in m.m. 
 B. mega.  
R 
B. subtillis  
R 
E. coli.  
R 
P. fluorescens.  
R 
A. awamori. 
R 
 3-OH C6H4 (20) 4-OH C6H4 (20) 3-OH C6H4 (23) 4-OH C6H4 (23) C6H5 (20) 
 4-OCH3 C6H4 (19) 4-NO2 C6H4 (21) 4-OH C6H4 (22) 4-NO2 C6H4 (21) 3-OH C6H4 (21) 
 4-OH, 3-OCH3  4-OH, 3-OCH3  3-NO2 C6H4 (21) 
 C6H4 (19)  C6H4 (18)  C4H3O (22) 
 3-NO2 C6H4 (23)     
 4-NO2 C6H4 (24)     
    
Comparable activity with known standard drugs 
Ampicilin             50 µg 23 18 17 27 - 
Chloramphenicol      “ 24 19 25 26 - 
Norfloxacin              “ 24 19 25 26 - 
Greseofulvin              “ - - - - 23 
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REACTION SCHEME 
R
NCl
N
N
NCl
O
N
H
O
NCl
N
N
NCl
O
N
H
O
RO
N
N
N
O
N
H
O
Cl
NHCl
Cl
HCl
N
N
N
N
H
O
Cl
Cl
N
N
N
Cl
Cl Cl
O
NH
2
N
R
N
NCl
N
N
NCl
O
N
H
N
N
N
N N
NH
2
(Type-XVII) R = Aryl
40 % Aq. NaOH
110 °C , 1,4-Dioxane
Aq. NaOH
NaOCH3
RT , Methanol
0 °C , Acetone
   Aq. NaOH
RT , Methanol
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EXPERIMENTAL 
 
SYNTHESIS OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-N-(1,2,4-TRIAZOLE) 
AMINO]}-6-[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1, 3, 5-
TRIAZINE.  
 
(A) Synthesis of 2-(4'-Acetyl phenyl amino)-4, 6-dichloro-1,2,5-triazine  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(B) Synthesis of 2-(4'-Acetyl phenyl amino)-6-chloro-4-methoxy-1,3,5-triazine 
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(C) Synthesis of 2-(4'-Acetyl phenyl amino)-6-[Bis(2"-chloro ethyl) amino]-4-
methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(D) Synthesis of 2-{4'-[3"-(4""-methoxy phenyl)-2"-propene-1"-one) phenyl 
amino}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-triazine.  
 For synthesis, see Part-I, Section-I, Page no. 36-38. 
 
(E) Synthesis of 2-{4'-[3"(4""-Methoxy phenyl)-2"-propene-1-N-(1,2,4-
triazole) amino]}-6-[Bis(2"'-chloroethyl) amino]-4-methoxy-1,3,5-
triazine.  
 A mixture of 2-{4'-[3"-(4""-methoxy phenyl)-2"-propene-1"-one] phenyl 
amino}-6-[Bis(2"'-chloro ethyl) amino]-4-methoxy-1,3,5-triazine(5.02 gm, 
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0.01 M); 1-amino-1,3,4-triazole (0.76 gm; 0.01 M) and alcoholic KOH, the 
reaction mixture was refluxed fo 10 hrs. at 100º C. temp. The reaction mixture 
poured into crushed ice, filtered,dried and crystallised from dioxane, Yield : 
79% ; M.P. 185º C. (Found : C : 54.90; H : 4.73; N : 22.15, C26H27O2N9Cl2 
required C : 54.92; H : 4.75; N : 22.18%).  
  Similarly other compounds were prepared and their physical data 
recorded in Table no. 33  
 
(F) Antimicrobial activity of 2-{4'-[3"-aryl)-2"-propene-1"-N-(1,2,4-triazole) 
amino]}-6-[Bis (2"'-chloro ethyl) amino]-4- methoxy-1,3,5-triazine.  
 
The antimicrobial testing was carried out as described in Part-I, Section-I, 
Page no. 39-41. 
 
 The zone of inhibition of the test solutions are recorded in Table no. 34. 
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TABLE NO : 33 : PHYSICAL CONSTANTS OF 2-{4'-[(3"-ARYL)-2"-PROPENE-1"-N-(1,2,4-TRIAZOLE) AMINO]}-6-[BIS(2"'-
CHLORO ETHYL) AMINO]-4-METHOXY-1, 3, 5-TRIAZINE.  
 
Sr. 
No. 
R Molecular 
Formula 
M.P. 
.c 
Yield 
% 
% of Nitrogen 
Calcd Found 
1. C6H5 C25H25Cl2N9O 238 57 23.41 23.39 
2. 2-OH C6H4 C25H25Cl2N9O2 232 62 22.74 22.71 
3. 3-OH C6H4 C25H25Cl2N9O2 215 65 22.74 22.72 
4. 4-OH C6H4 C25H25Cl2N9O2 223 72 22.74 22.69 
5. 4-OCH3 C6H4 C26H27Cl2N9O2 185 79 22.18 22.15 
6. 4-OH, 3-OCH3 C6H3 C26H27Cl2N9O3 222 74 21.57 21.53 
7. 4-Br. C6H4 C25H24BrCl2N9O 120 80 20.42 20.41 
8. 3-NO2 C6H4 C25H24Cl2N10O3 182 83 24.01 24.00 
9. 4-NO2 C6H4 C25H24Cl2N10O3 193 69 24.01 23.99 
10 4-N,N(CH3)2 C6H4 C27H30Cl2N10O 169 72 24.09 24.05 
11. C4H3O (Furfuryl) C23H23Cl2N9O2 242 95 23.86 23.81 
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TABLE NO : 34 : ANTIMICROBIAL ACTIVITY OF 2-{4" [3"-ARYL)-2"-PROPENE-1"-N-(1, 2, 4 – TRIAZOLE) AMINO}-6-
[BIS(2"'-CHLORO ETHYL) AMINO]-4-METHOXY-1,3,5-TRIAZINE. 
 
Sr. 
No. 
R Antibacterial activity 
Zone of inhibition in mm. 
Antifungal activity 
Zone of inhibition in mm. 
  B. mega. B. subtillis E. coli. P. fluorescens A. awamori 
1 C6H5 16 17 14 19 20 
2 2-OH C6H4 15 19 17 20 17 
3 3-OH C6H4 20 14 23 18 21 
4 4-OH C6H4 18 20 22 23 19 
5 4-OCH3 C6H4 19 12 13 20 19 
6 4-OH, 3-OCH3 C6H3 19 15 18 18 16 
7 4-Br. C6H4 16 14 17 17 14 
8 3-NO2 C6H4 23 17 15 19 21 
9 4-NO2 C6H4 24 21 14 21 16 
10 4-N,N(CH3)2 C6H4 15 15 19 18 17 
11 C4H3O (Furfuryl) 13 17 18 17 22 
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Chalcones are Phenyl styrylketones containing reactive keto ethylenic group (-CO-
CH=CH-). Liturature serve reveals that chalcones derivatives possess antibacterial, antiviral, 
antifungal activities. Hence, it was thought worth while to synthesis chalcones (4a-4k) 
derivatives. The constitution of the products delinated by  IR,  
1
H NMR, Mass spectral studies 
and TLC.  The products are evaluated their antimicrobial activity against Gram +ve bacteria, 
Gram –ve bacteria and fungi. 
R
NCl
N
N
NCl
O
N
H
O
(4a-4k) R = Aryl  
(An Indian Journal : Organic Chemistry) 
 
(2) Synthesis and Antimicrobial activity of 2-{4'-[(5"-Aryl)-isoxazole-3"-yl]- 
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better potency to synthesize isoxazoles  (4a-4k) derivatives. The constitution of the 
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active as antineoplastic agents with a view of above facts. Some new pyrazolines (4a-4k), 
(5a-5k) have been synthesized. The constitution of the products delinated by  IR,  
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